{"id":16605,"date":"2025-07-15T09:02:37","date_gmt":"2025-07-15T06:02:37","guid":{"rendered":"https:\/\/medicalpointinternational.com\/aerzte\/prof-mehmet-mutlu-meydanli\/"},"modified":"2026-06-22T09:18:04","modified_gmt":"2026-06-22T06:18:04","slug":"prof-mehmet-mutlu-meydanli","status":"publish","type":"page","link":"https:\/\/medicalpointinternational.com\/de\/aerzte\/prof-mehmet-mutlu-meydanli\/","title":{"rendered":"Prof. Dr. med. Mehmet Mutlu Meydanl\u0131"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><div data-elementor-type=\"wp-page\" data-elementor-id=\"16605\" class=\"elementor elementor-16605 elementor-2613\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-81a393c e-flex e-con-boxed e-con e-parent\" data-id=\"81a393c\" data-element_type=\"container\" data-settings='{\"background_background\":\"slideshow\",\"background_slideshow_gallery\":[{\"id\":1509,\"url\":\"https:\\\/\\\/medicalpointinternational.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/MedicalPoint-International-Hospital-About-Us-Pic.webp\"}],\"background_slideshow_loop\":\"yes\",\"background_slideshow_slide_duration\":5000,\"background_slideshow_slide_transition\":\"fade\",\"background_slideshow_transition_duration\":500}'>\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-6274dc7 e-con-full e-flex e-con e-child\" data-id=\"6274dc7\" data-element_type=\"container\" data-settings='{\"background_background\":\"classic\"}'>\n\t\t<div class=\"elementor-element elementor-element-f710ec2 e-con-full e-flex e-con e-child\" data-id=\"f710ec2\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1c094f1 elementor-widget elementor-widget-image\" data-id=\"1c094f1\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"572\" src=\"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2026\/05\/PROF_MEHMET_MUTLU_MEYDANLI-_compressed-1024x732.webp\" class=\"attachment-large size-large wp-image-73152\" alt=\"\" srcset=\"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2026\/05\/PROF_MEHMET_MUTLU_MEYDANLI-_compressed-1024x732.webp 1024w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2026\/05\/PROF_MEHMET_MUTLU_MEYDANLI-_compressed-300x214.webp 300w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2026\/05\/PROF_MEHMET_MUTLU_MEYDANLI-_compressed-768x549.webp 768w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2026\/05\/PROF_MEHMET_MUTLU_MEYDANLI-_compressed-1536x1098.webp 1536w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2026\/05\/PROF_MEHMET_MUTLU_MEYDANLI-_compressed.webp 1652w\" sizes=\"(max-width: 800px) 100vw, 800px\" title=\"\">\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-8533f4d e-con-full e-flex e-con e-child\" data-id=\"8533f4d\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2eb3f6f elementor-widget elementor-widget-heading\" data-id=\"2eb3f6f\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Prof. Dr. med. Mehmet Mutlu Meydanl&#305;<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-38cddca elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"38cddca\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<i style=\"color:#ffffff\" class=\"fas fa-map-marker-alt\"><\/i> <span>MedicalPoint Gaziantep Krankenhaus<\/span>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-64a2fce elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"64a2fce\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<span>Gyn&auml;kologische Onkologie<\/span>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4f24042 e-con-full e-flex e-con e-child\" data-id=\"4f24042\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-76197eb e-con-full e-flex e-con e-child\" data-id=\"76197eb\" data-element_type=\"container\" data-settings='{\"background_background\":\"classic\"}'>\n\t\t\t\t<div class=\"elementor-element elementor-element-fe8c578 elementor-widget elementor-widget-heading\" data-id=\"fe8c578\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">R&uuml;ckruf anfordern<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-657195d ekit_wpForms_container-form-button-full-width elementor-widget-mobile__width-initial elementor-widget elementor-widget-elementskit-wp-forms\" data-id=\"657195d\" data-element_type=\"widget\" data-widget_type=\"elementskit-wp-forms.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"ekit-wid-con ekit_wpForms_container\"><div class=\"wpforms-container wpforms-container-full wpforms-render-modern\" id=\"wpforms-2447\"><form id=\"wpforms-form-2447\" class=\"wpforms-validate wpforms-form wpforms-ajax-form\" data-formid=\"2447\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/de\/wp-json\/wp\/v2\/pages\/16605\" data-token=\"ec575e0d1b01c4c7c39de324e31a89e1\" data-token-time=\"1782243307\"><noscript class=\"wpforms-error-noscript\">Bitte aktivieren Sie JavaScript in Ihrem Browser, um dieses Formular auszuf&uuml;llen.<\/noscript><div class=\"wpforms-hidden\" id=\"wpforms-error-noscript\">Bitte aktivieren Sie JavaScript in Ihrem Browser, um dieses Formular auszuf&uuml;llen.<\/div><div class=\"wpforms-field-container\"><div id=\"wpforms-2447-field_1-container\" class=\"wpforms-field wpforms-field-name\" data-field-id=\"1\"><fieldset><legend class=\"wpforms-field-label wpforms-label-hide\" aria-hidden=\"false\">Name <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/legend><div class=\"wpforms-field-row wpforms-field-large\"><div class=\"wpforms-field-row-block wpforms-first wpforms-one-half\"><input type=\"text\" id=\"wpforms-2447-field_1\" class=\"wpforms-field-name-first wpforms-field-required\" name=\"wpforms[fields][1][first]\" placeholder=\"Name\" aria-errormessage=\"wpforms-2447-field_1-error\" required><label for=\"wpforms-2447-field_1\" class=\"wpforms-field-sublabel after wpforms-sublabel-hide\">Erste<\/label><\/div><div class=\"wpforms-field-row-block wpforms-one-half\"><input type=\"text\" id=\"wpforms-2447-field_1-last\" class=\"wpforms-field-name-last wpforms-field-required\" name=\"wpforms[fields][1][last]\" placeholder=\"Nachname\" aria-errormessage=\"wpforms-2447-field_1-last-error\" required><label for=\"wpforms-2447-field_1-last\" class=\"wpforms-field-sublabel after wpforms-sublabel-hide\">Letzte<\/label><\/div><\/div><\/fieldset><\/div><div id=\"wpforms-2447-field_2-container\" class=\"wpforms-field wpforms-field-phone\" data-field-id=\"2\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-2447-field_2\" aria-hidden=\"false\">Telefon <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"tel\" id=\"wpforms-2447-field_2\" class=\"wpforms-field-large wpforms-field-required wpforms-smart-phone-field\" data-rule-smart-phone-field=\"true\" name=\"wpforms[fields][2]\" placeholder=\"Telefon\" aria-label=\"Telefon\" aria-errormessage=\"wpforms-2447-field_2-error\" required><\/div><div id=\"wpforms-2447-field_4-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"4\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-2447-field_4\" aria-hidden=\"false\">E-Mail <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"email\" id=\"wpforms-2447-field_4\" class=\"wpforms-field-large wpforms-field-required\" name=\"wpforms[fields][4]\" placeholder=\"E-Mail\" spellcheck=\"false\" aria-errormessage=\"wpforms-2447-field_4-error\" required><\/div><div id=\"wpforms-2447-field_7-container\" class=\"wpforms-field wpforms-field-select wpforms-field-select-style-modern\" data-field-id=\"7\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-2447-field_7\" aria-hidden=\"false\">Land <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><select id=\"wpforms-2447-field_7\" class=\"wpforms-field-large wpforms-field-required choicesjs-select\" data-size-class=\"wpforms-field-row wpforms-field-large\" data-search-enabled=\"1\" name=\"wpforms[fields][7]\" required=\"required\"><option value=\"\" class=\"placeholder\" disabled selected>Land<\/option><option value=\"Afghanistan\">Afghanistan<\/option><option value=\"Albanien\">Albanien<\/option><option value=\"Algerien\">Algerien<\/option><option value=\"Andorra\">Andorra<\/option><option value=\"Angola\">Angola<\/option><option value=\"Antigua und Barbuda\">Antigua und Barbuda<\/option><option value=\"Argentinien\">Argentinien<\/option><option value=\"Armenien\">Armenien<\/option><option value=\"Australien\">Australien<\/option><option value=\"&Ouml;sterreich\">&Ouml;sterreich<\/option><option value=\"Aserbaidschan\">Aserbaidschan<\/option><option value=\"Die Bahamas\">Die Bahamas<\/option><option value=\"Bahrain\">Bahrain<\/option><option value=\"Bangladesch\">Bangladesch<\/option><option value=\"Barbados\">Barbados<\/option><option value=\"Wei&szlig;russland\">Wei&szlig;russland<\/option><option value=\"Belgien\">Belgien<\/option><option value=\"Belize\">Belize<\/option><option value=\"Benin\">Benin<\/option><option value=\"Bhutan\">Bhutan<\/option><option value=\"Bolivien\">Bolivien<\/option><option value=\"Bosnien und Herzegowina\">Bosnien und Herzegowina<\/option><option value=\"Botswana\">Botswana<\/option><option value=\"Brasilien\">Brasilien<\/option><option value=\"Brunei\">Brunei<\/option><option value=\"Bulgarien\">Bulgarien<\/option><option value=\"Burkina Faso\">Burkina Faso<\/option><option value=\"Burundi\">Burundi<\/option><option value=\"Cabo Verde\">Cabo Verde<\/option><option value=\"Kambodscha\">Kambodscha<\/option><option value=\"Kamerun\">Kamerun<\/option><option value=\"Kanada\">Kanada<\/option><option value=\"Zentralafrikanische Republik\">Zentralafrikanische Republik<\/option><option value=\"Chad\">Chad<\/option><option value=\"Chile\">Chile<\/option><option value=\"China\">China<\/option><option value=\"Kolumbien\">Kolumbien<\/option><option value=\"Komoren\">Komoren<\/option><option value=\"Kongo, Demokratische Republik\">Kongo, Demokratische Republik<\/option><option value=\"Kongo, Republik der\">Kongo, Republik der<\/option><option value=\"Costa Rica\">Costa Rica<\/option><option value=\"C&ocirc;te d'Ivoire\">C&ocirc;te d'Ivoire<\/option><option value=\"Kroatien\">Kroatien<\/option><option value=\"Kuba\">Kuba<\/option><option value=\"Zypern\">Zypern<\/option><option value=\"Tschechische Republik\">Tschechische Republik<\/option><option value=\"D&auml;nemark\">D&auml;nemark<\/option><option value=\"Dschibuti\">Dschibuti<\/option><option value=\"Dominica\">Dominica<\/option><option value=\"Dominikanische Republik\">Dominikanische Republik<\/option><option value=\"Osttimor (Timor-Leste)\">Osttimor (Timor-Leste)<\/option><option value=\"Ecuador\">Ecuador<\/option><option value=\"&Auml;gypten\">&Auml;gypten<\/option><option value=\"El Salvador\">El Salvador<\/option><option value=\"&Auml;quatorial-Guinea\">&Auml;quatorial-Guinea<\/option><option value=\"Eritrea\">Eritrea<\/option><option value=\"Estland\">Estland<\/option><option value=\"Eswatini\">Eswatini<\/option><option value=\"&Auml;thiopien\">&Auml;thiopien<\/option><option value=\"Fidschi\">Fidschi<\/option><option value=\"Finnland\">Finnland<\/option><option value=\"Frankreich\">Frankreich<\/option><option value=\"Ghana\">Ghana<\/option><option value=\"Griechenland\">Griechenland<\/option><option value=\"Grenada\">Grenada<\/option><option value=\"Guatemala\">Guatemala<\/option><option value=\"Guinea\">Guinea<\/option><option value=\"Guinea-Bissau\">Guinea-Bissau<\/option><option value=\"Guyana\">Guyana<\/option><option value=\"Haiti\">Haiti<\/option><option value=\"Honduras\">Honduras<\/option><option value=\"Ungarn\">Ungarn<\/option><option value=\"Island\">Island<\/option><option value=\"Indien\">Indien<\/option><option value=\"Indonesien\">Indonesien<\/option><option value=\"Iran\">Iran<\/option><option value=\"Irak\">Irak<\/option><option value=\"Irland\">Irland<\/option><option value=\"Israel\">Israel<\/option><option value=\"Italien\">Italien<\/option><option value=\"Jamaika\">Jamaika<\/option><option value=\"Japan\">Japan<\/option><option value=\"Kasachstan\">Kasachstan<\/option><option value=\"Kenia\">Kenia<\/option><option value=\"Kiribati\">Kiribati<\/option><option value=\"Korea, Nord\">Korea, Nord<\/option><option value=\"Korea, S&uuml;d\">Korea, S&uuml;d<\/option><option value=\"Kosovo\">Kosovo<\/option><option value=\"Kuwait\">Kuwait<\/option><option value=\"Kirgisistan\">Kirgisistan<\/option><option value=\"Laos\">Laos<\/option><option value=\"Lettland\">Lettland<\/option><option value=\"Libanon\">Libanon<\/option><option value=\"Lesotho\">Lesotho<\/option><option value=\"Liechtenstein\">Liechtenstein<\/option><option value=\"Litauen\">Litauen<\/option><option value=\"Luxemburg\">Luxemburg<\/option><option value=\"Madagaskar\">Madagaskar<\/option><option value=\"Malawi\">Malawi<\/option><option value=\"Malaysia\">Malaysia<\/option><option value=\"Malediven\">Malediven<\/option><option value=\"Mali\">Mali<\/option><option value=\"Malta\">Malta<\/option><option value=\"Mauritius\">Mauritius<\/option><option value=\"Mexiko\">Mexiko<\/option><option value=\"Mikronesien, F&ouml;derierte Staaten von\">Mikronesien, F&ouml;derierte Staaten von<\/option><option value=\"Moldawien\">Moldawien<\/option><option value=\"Monaco\">Monaco<\/option><option value=\"Mongolei\">Mongolei<\/option><option value=\"Montenegro\">Montenegro<\/option><option value=\"Marokko\">Marokko<\/option><option value=\"Mosambik\">Mosambik<\/option><option value=\"Myanmar (Birma)\">Myanmar (Birma)<\/option><option value=\"Namibia\">Namibia<\/option><option value=\"Nauru\">Nauru<\/option><option value=\"Nepal\">Nepal<\/option><option value=\"Niederlande\">Niederlande<\/option><option value=\"Neuseeland\">Neuseeland<\/option><option value=\"Nicaragua\">Nicaragua<\/option><option value=\"Niger\">Niger<\/option><option value=\"Nigeria\">Nigeria<\/option><option value=\"Nord-Mazedonien\">Nord-Mazedonien<\/option><option value=\"Norwegen\">Norwegen<\/option><option value=\"Oman\">Oman<\/option><option value=\"Pakistan\">Pakistan<\/option><option value=\"Palau\">Palau<\/option><option value=\"Panama\">Panama<\/option><option value=\"Papua-Neuguinea\">Papua-Neuguinea<\/option><option value=\"Paraguay\">Paraguay<\/option><option value=\"Peru\">Peru<\/option><option value=\"Philippinen\">Philippinen<\/option><option value=\"Polen\">Polen<\/option><option value=\"Portugal\">Portugal<\/option><option value=\"Katar\">Katar<\/option><option value=\"Rum&auml;nien\">Rum&auml;nien<\/option><option value=\"Russland\">Russland<\/option><option value=\"Ruanda\">Ruanda<\/option><option value=\"St. Kitts und Nevis\">St. Kitts und Nevis<\/option><option value=\"St. Lucia\">St. Lucia<\/option><option value=\"St. Vincent und die Grenadinen\">St. Vincent und die Grenadinen<\/option><option value=\"Samoa\">Samoa<\/option><option value=\"San Marino\">San Marino<\/option><option value=\"Sao Tome und Principe\">Sao Tome und Principe<\/option><option value=\"Saudi-Arabien\">Saudi-Arabien<\/option><option value=\"Senegal\">Senegal<\/option><option value=\"Serbien\">Serbien<\/option><option value=\"Seychellen\">Seychellen<\/option><option value=\"Sierra Leone\">Sierra Leone<\/option><option value=\"Singapur\">Singapur<\/option><option value=\"Slowakei\">Slowakei<\/option><option value=\"Slowenien\">Slowenien<\/option><option value=\"Salomonen\">Salomonen<\/option><option value=\"Somalia\">Somalia<\/option><option value=\"S&uuml;dafrika\">S&uuml;dafrika<\/option><option value=\"Spanien\">Spanien<\/option><option value=\"Sri Lanka\">Sri Lanka<\/option><option value=\"Sudan\">Sudan<\/option><option value=\"Sudan, S&uuml;d\">Sudan, S&uuml;d<\/option><option value=\"Surinam\">Surinam<\/option><option value=\"Schweden\">Schweden<\/option><option value=\"Schweiz\">Schweiz<\/option><option value=\"Syrien\">Syrien<\/option><option value=\"Taiwan\">Taiwan<\/option><option value=\"Tadschikistan\">Tadschikistan<\/option><option value=\"Tansania\">Tansania<\/option><option value=\"Thailand\">Thailand<\/option><option value=\"Togo\">Togo<\/option><option value=\"Tonga\">Tonga<\/option><option value=\"Trinidad und Tobago\">Trinidad und Tobago<\/option><option value=\"Tunesien\">Tunesien<\/option><option value=\"T&uuml;rkei\">T&uuml;rkei<\/option><option value=\"Turkmenistan\">Turkmenistan<\/option><option value=\"Tuvalu\">Tuvalu<\/option><option value=\"Uganda\">Uganda<\/option><option value=\"Ukraine\">Ukraine<\/option><option value=\"Vereinigte Arabische Emirate\">Vereinigte Arabische Emirate<\/option><option value=\"Vereinigtes K&ouml;nigreich\">Vereinigtes K&ouml;nigreich<\/option><option value=\"Vereinigte Staaten\">Vereinigte Staaten<\/option><option value=\"Uruguay\">Uruguay<\/option><option value=\"Usbekistan\">Usbekistan<\/option><option value=\"Vanuatu\">Vanuatu<\/option><option value=\"Vatikanstadt\">Vatikanstadt<\/option><option value=\"Venezuela\">Venezuela<\/option><option value=\"Vietnam\">Vietnam<\/option><option value=\"Jemen\">Jemen<\/option><option value=\"Sambia\">Sambia<\/option><option value=\"Simbabwe\">Simbabwe<\/option><\/select><\/div><\/div><!-- .wpforms-field-container --><div class=\"wpforms-submit-container\"><input type=\"hidden\" name=\"wpforms[id]\" value=\"2447\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/16605\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-2447\" class=\"wpforms-submit\" data-alt-text=\"Senden Sie...\" data-submit-text=\"Einreichen\" aria-live=\"assertive\" value=\"wpforms-submit\">Einreichen<\/button><img decoding=\"async\" src=\"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg\" class=\"wpforms-submit-spinner\" style=\"display: none;\" width=\"26\" height=\"26\" alt=\"Wird geladen\" title=\"\"><\/div><\/form><\/div>  <!-- .wpforms-container --><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-240e44b e-flex e-con-boxed e-con e-parent\" data-id=\"240e44b\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f029fc2 elementor-widget elementor-widget-heading\" data-id=\"f029fc2\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ausbildung und Fachwissen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5b176ae elementor-widget elementor-widget-text-editor\" data-id=\"5b176ae\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"135\" data-end=\"422\"><li data-start=\"135\" data-end=\"204\"><p data-start=\"137\" data-end=\"204\"><strong data-start=\"137\" data-end=\"145\">1994<\/strong> - Medizinische Fakult&auml;t der Universit&auml;t Ankara - Abschluss in Medizin<\/p><\/li><li data-start=\"205\" data-end=\"331\"><p data-start=\"207\" data-end=\"331\"><strong data-start=\"207\" data-end=\"215\">1999<\/strong> - Z&uuml;beyde Han&#305;m Etlik Krankenhaus f&uuml;r Frauenkrankheiten, Geburtshilfe und Forschung - Facharzt f&uuml;r Geburtshilfe und Gyn&auml;kologie<\/p><\/li><li data-start=\"332\" data-end=\"422\"><p data-start=\"334\" data-end=\"422\"><strong data-start=\"334\" data-end=\"342\">2011<\/strong> - Gesundheitsministerium der T&uuml;rkei - Spezialisierung in gyn&auml;kologischer Onkologie Chirurgie<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-099ae2c elementor-widget elementor-widget-heading\" data-id=\"099ae2c\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Berufserfahrung<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9020dd5 elementor-widget elementor-widget-text-editor\" data-id=\"9020dd5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"135\" data-end=\"422\">\n\n \t<li data-start=\"458\" data-end=\"556\">\n<p data-start=\"460\" data-end=\"556\"><strong data-start=\"460\" data-end=\"473\">2017-2020<\/strong> - Professor, Health Sciences University, Abteilung f&uuml;r Geburtshilfe und Gyn&auml;kologie<\/p>\n<\/li>\n \t<li data-start=\"557\" data-end=\"655\">\n<p data-start=\"559\" data-end=\"655\"><strong data-start=\"559\" data-end=\"572\">2019-2020<\/strong> - Verwaltungsleiter, Klinik f&uuml;r Gyn&auml;kologische Onkologie und Chirurgie, St&auml;dtisches Krankenhaus Ankara<\/p>\n<\/li>\n \t<li data-start=\"656\" data-end=\"779\">\n<p data-start=\"658\" data-end=\"779\"><strong data-start=\"658\" data-end=\"671\">2013-2019<\/strong> - Administrative und p&auml;dagogische Leitung, Klinik f&uuml;r gyn&auml;kologische Onkologie und Chirurgie, Dr. Zekai Tahir Suam Hospital<\/p>\n<\/li>\n \t<li data-start=\"780\" data-end=\"907\">\n<p data-start=\"782\" data-end=\"907\"><strong data-start=\"782\" data-end=\"795\">2010-2013<\/strong> - Professor und Vorsitzender, Medizinische Fakult&auml;t der Adnan Menderes Universit&auml;t, Abteilung f&uuml;r Geburtshilfe und Gyn&auml;kologie<\/p>\n<\/li>\n \t<li data-start=\"908\" data-end=\"1016\">\n<p data-start=\"910\" data-end=\"1016\"><strong data-start=\"910\" data-end=\"923\">2009-2010<\/strong> - Professor, Medizinische Fakult&auml;t der &#304;n&ouml;n&uuml; Universit&auml;t, Abteilung f&uuml;r Geburtshilfe und Gyn&auml;kologie<\/p>\n<\/li>\n \t<li data-start=\"1017\" data-end=\"1135\">\n<p data-start=\"1019\" data-end=\"1135\"><strong data-start=\"1019\" data-end=\"1032\">2004-2009<\/strong> - Au&szlig;erordentlicher Professor, Medizinische Fakult&auml;t der &#304;n&ouml;n&uuml; Universit&auml;t, Abteilung f&uuml;r Geburtshilfe und Gyn&auml;kologie<\/p>\n<\/li>\n \t<li data-start=\"1136\" data-end=\"1216\">\n<p data-start=\"1138\" data-end=\"1216\"><strong data-start=\"1138\" data-end=\"1151\">2004-2006<\/strong> - Chefarzt, Medizinisches Zentrum der &#304;n&ouml;n&uuml; Universit&auml;t Turgut &Ouml;zal<\/p>\n<\/li>\n \t<li data-start=\"1217\" data-end=\"1335\">\n<p data-start=\"1219\" data-end=\"1335\"><strong data-start=\"1219\" data-end=\"1232\">2001-2004<\/strong> - Assistenzprofessor, Medizinische Fakult&auml;t der &#304;n&ouml;n&uuml; Universit&auml;t, Abteilung f&uuml;r Geburtshilfe und Gyn&auml;kologie<\/p>\n<\/li>\n \t<li data-start=\"1336\" data-end=\"1457\">\n<p data-start=\"1338\" data-end=\"1457\"><strong data-start=\"1338\" data-end=\"1351\">2002-2004<\/strong> - Stellvertretender Chefarzt und Leiter des Beschaffungsausschusses, &#304;n&ouml;n&uuml; Universit&auml;t Turgut &Ouml;zal Medical Center<\/p>\n<\/li>\n \t<li data-start=\"1458\" data-end=\"1596\">\n<p data-start=\"1460\" data-end=\"1596\"><strong data-start=\"1460\" data-end=\"1473\">1999-2001<\/strong> - Fach&auml;rztin, Klinik f&uuml;r Gyn&auml;kologische Onkologie, Z&uuml;beyde Han&#305;m Etlik Krankenhaus f&uuml;r Frauenkrankheiten, Geburtshilfe und Forschung<\/p>\n<\/li>\n<\/ul>\n\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a57c02a elementor-widget elementor-widget-heading\" data-id=\"a57c02a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Berufliche Mitgliedschaften<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-81434d8 elementor-widget elementor-widget-text-editor\" data-id=\"81434d8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"135\" data-end=\"422\">\n\n \t<li data-start=\"1633\" data-end=\"1694\">\n<p data-start=\"1635\" data-end=\"1694\">T&uuml;rkische Gesellschaft f&uuml;r Gyn&auml;kologie und Geburtshilfe (seit 2001)<\/p>\n<\/li>\n \t<li data-start=\"1695\" data-end=\"1780\">\n<p data-start=\"1697\" data-end=\"1780\">T&uuml;rkische Gesellschaft f&uuml;r Gyn&auml;kologische Onkologie (seit 2002)<br data-start=\"1749\" data-end=\"1752\">(Vorstandsmitglied 2017-2019)<\/p>\n<\/li>\n \t<li data-start=\"1781\" data-end=\"1939\">\n<p data-start=\"1783\" data-end=\"1939\">Europ&auml;ische Gesellschaft f&uuml;r Gyn&auml;kologische Onkologie (seit 2007)<br data-start=\"1839\" data-end=\"1842\">(ENGOT Rare Tumor Group Repr&auml;sentant der T&uuml;rkischen Gesellschaft f&uuml;r Gyn&auml;kologische Onkologie seit 2017)<\/p>\n<\/li>\n \t<li data-start=\"1940\" data-end=\"2030\">\n<p data-start=\"1942\" data-end=\"2030\">Gesellschaft f&uuml;r zervikale Pathologie und Kolposkopie (seit 2009)<br data-start=\"1998\" data-end=\"2001\">(Vorstandsmitglied seit 2014)<\/p>\n<\/li>\n \t<li data-start=\"2031\" data-end=\"2152\">\n<p data-start=\"2033\" data-end=\"2152\">Middle East and Mediterranean Association of Gynecologic Oncologists (MEMAGO) (seit 2016)<br data-start=\"2123\" data-end=\"2126\">(Sekret&auml;rin seit 2018)<\/p>\n<\/li>\n<\/ul>\n\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0ebc480 elementor-widget elementor-widget-heading\" data-id=\"0ebc480\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ausgew&auml;hlte Forschungspublikationen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7ab529e elementor-widget elementor-widget-text-editor\" data-id=\"7ab529e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"2195\" data-end=\"4371\">\n \t<li data-start=\"2195\" data-end=\"2810\">\n<p data-start=\"2197\" data-end=\"2810\">CHIVA Luis, ZANAGNOLO Vanna, QUERLEU Denis, MARTIN-CALVO Nerea, AREVALO-SERRANO Juan, CAPILNA Mihai Emil, FAGOTTI Anna, KUCUKMETIN Ali, MOM Constantijne, CHAKALOVA Galina, ALIYEV Shamistan, MALZONI Mario, NARDUCCI Fabrice, ARENCIBIA Octavio, RASPAGLIESI Francesco, TOPTAS Tayfun, CIBULA David, KAIDAROVA Dilyara, MEYDANLI Mehmet Mutlu, et al. <strong data-start=\"2540\" data-end=\"2557\">SUCCOR-Studie:<\/strong> Eine internationale europ&auml;ische Kohortenbeobachtungsstudie zum Vergleich der minimal-invasiven Chirurgie mit der offenen abdominalen radikalen Hysterektomie bei Patienten mit Geb&auml;rmutterhalskrebs im Stadium IB1. <em data-start=\"2735\" data-end=\"2757\">Int J Gynecol Cancer<\/em>. 2020; doi:10.1136\/ijgc-2020-001506. PMID: 32788262.<\/p>\n<\/li>\n \t<li data-start=\"2812\" data-end=\"3062\">\n<p data-start=\"2814\" data-end=\"3062\">ASLAN Koray, MEYDANLI Mehmet Mutlu, AKILLI H&uuml;seyin u. a. Hat die Lymphknotenquote eine prognostische Bedeutung bei maximal zytoreduziertem, lymphknotenpositivem, niedriggradigem ser&ouml;sem Ovarialkarzinom? <em data-start=\"3003\" data-end=\"3025\">Arch Gynecol Obstet.<\/em> 2020;302(1):183&ndash;190. PMID: 32409929. <\/p>\n<\/li>\n \t<li data-start=\"3064\" data-end=\"3422\">\n<p data-start=\"3066\" data-end=\"3422\">ASLAN Koray, MEYDANLI Mehmet Mutlu, OZ Murat, TOHMA Yusuf Ayta&ccedil;, HABERAL Ali, AYHAN Ali. Der prognostische Wert des Lymphknotenanteils bei Patientinnen mit Geb&auml;rmutterhalskrebs im Stadium IIIC, bei denen eine radikale Hysterektomie mit systematischer pelviner und paraaortaler Lymphadenektomie als Prim&auml;rbehandlung indiziert ist. <em data-start=\"3344\" data-end=\"3362\">J Gynecol Oncol.<\/em> 2020;31(1):e1. doi: 10.3802\/jgo.2020.31.e1. PMID: 31788991. <\/p>\n<\/li>\n \t<li data-start=\"3424\" data-end=\"3722\">\n<p data-start=\"3426\" data-end=\"3722\">YORGANCI Ay&ccedil;a&#287;, MEYDANLI Mehmet Mutlu, KADIO&#286;LU Nezahat u. a. Inzidenz und Verlauf von okkulten Uterussarkomen: Eine multizentrische Studie an 18.604 Operationen, die aufgrund eines vermuteten Uterusleiomyoms durchgef&uuml;hrt wurden. <em data-start=\"3623\" data-end=\"3653\">J Gynecol Obstet Hum Reprod.<\/em> 2020;49(1):101631. doi: 10.1016\/j.jogoh.2019.101631. PMID: 31499285. <\/p>\n<\/li>\n \t<li data-start=\"3724\" data-end=\"3995\">\n<p data-start=\"3726\" data-end=\"3995\">KAHRAMANOGLU, &#304;lker; MEYDANLI, Mehmet Mutlu; TARANENKA, S. et al. SATEN III &ndash; Geteilte adjuvante Therapie bei Endometriumkarzinomen im Stadium III: eine internationale, multizentrische Studie. <em data-start=\"3899\" data-end=\"3922\">Int J Gynecol Cancer.<\/em> Okt. 2019;29(8):1271&ndash;1279. doi: 10.1136\/ijgc-2019-000643. PMID: 31481453. <\/p>\n<\/li>\n \t<li data-start=\"3997\" data-end=\"4371\">\n<p data-start=\"3999\" data-end=\"4371\">SELCUK Ilker, MEYDANLI Mehmet Mutlu, YALCIN Ibrahim, et al. Comparison of survival outcomes in optimally and maximum cytoreduced stage IIIC ovarian high-grade serous carcinoma: Women with only peritoneal tumor burden versus women with both peritoneal and lymphogenous dissemination. <em data-start=\"4284\" data-end=\"4308\">J Obstet Gynaecol Res.<\/em> 2019;45(10):2074-2081. doi: 10.1111\/jog.14075. PMID: 31373110. <\/p>\n<\/li>\n \t<li data-start=\"3997\" data-end=\"4371\">\n<p data-start=\"80\" data-end=\"404\"><strong data-start=\"80\" data-end=\"195\">MEYDANLI, Mehmet Mutlu; ASLAN, Koray; &Ouml;Z, Murat; MUFTUOGLU, Kamil Hakan; YALCIN, Ibrahim; ENG&#304;N-USTUN, Yaprak (2019).<\/strong><br data-start=\"195\" data-end=\"198\">Ein neuartiges multivariables Vorhersagemodell f&uuml;r die lymphatische Ausbreitung bei endometrioidem Endometriumkarzinom: Der Lymphknotenmetastasierungs-Risikoindex.<br data-start=\"338\" data-end=\"341\"><em data-start=\"341\" data-end=\"375\">Eur J Obstet Gynecol Reprod Biol<\/em> 240: 310&ndash;315. PMID: 31377459<\/p>\n<\/li><li><p data-start=\"406\" data-end=\"741\"><strong data-start=\"406\" data-end=\"520\">AYHAN Ali, ASLAN Koray, BULUT Ay&ccedil;a Nazl&#305;, AKILLI H&uuml;seyin, &Ouml;Z Murat, HABERAL Ali, MEYDANLI Mehmet Mutlu (2019).<\/strong><br data-start=\"520\" data-end=\"523\">Ist das &uuml;berarbeitete FIGO-Stadieneinteilungssystem von 2018 f&uuml;r Geb&auml;rmutterhalskrebs bei Frauen, bei denen zuvor das Stadium IB festgestellt wurde, prognostisch aussagekr&auml;ftiger als das FIGO-Stadieneinteilungssystem von 2009?<br data-start=\"675\" data-end=\"678\"><em data-start=\"678\" data-end=\"712\">Eur J Obstet Gynecol Reprod Biol<\/em> 240: 209&ndash;214. PMID: 31325847<\/p>\n<\/li><li><p data-start=\"743\" data-end=\"998\"><strong data-start=\"743\" data-end=\"876\">PEKCAN, Meryem Kuru; TOPFEDA&#304;S&#304;, &Ouml;ZKAN, Nazl&#305;; TOKMAK, Aytekin; &Ouml;ZAK&#350;&#304;T, G&uuml;lnur; KOSEM, Arzu; EREL, Ozcan; MEYDANLI, Mehmet Mutlu (2020).<\/strong> &bdquo;<br data-start=\"876\" data-end=\"879\">&ldquo; Thiol-\/Disulfid-Hom&ouml;ostase bei Patientinnen mit Molenschwangerschaften.<br data-start=\"942\" data-end=\"945\"><em data-start=\"945\" data-end=\"967\">Fetal Pediatr Pathol<\/em> 39 (2): 99&ndash;106. PMID: 31304870<\/p>\n<\/li><li><p data-start=\"1000\" data-end=\"1308\"><strong data-start=\"1000\" data-end=\"1098\">AYHAN Ali, ASLAN Koray, &Ouml;Z Murat, TOHMA Yusuf Ayta&ccedil;, KU&#350;&Ccedil;U Esra, MEYDANLI Mehmet Mutlu (2019).<\/strong><br data-start=\"1098\" data-end=\"1101\">Die Beteiligung der paraaortalen Lymphknoten im Lichte des &uuml;berarbeiteten FIGO-Staging-Systems von 2018 f&uuml;r Geb&auml;rmutterhalskrebs.<br data-start=\"1219\" data-end=\"1222\"><em data-start=\"1222\" data-end=\"1243\">Arch Gynecol Obstet<\/em> 300 (3): 675&ndash;82. doi: 10.1007\/s00404-019-05232-7. PMID: 31263988<\/p>\n<\/li><li><p data-start=\"1310\" data-end=\"1605\"><strong data-start=\"1310\" data-end=\"1484\">SAHIN Hanifi, YALCIN Ibrahim, SARI Mustafa Erkan, SAHIN Eda Adeviye, ASLAN Koray, AGLAMIS Ozgur, GULSEREN Varol, GUNGORDUK Kemal, MEYDANLI Mehmet Mutlu, AYHAN Ali (2019).<\/strong><br data-start=\"1484\" data-end=\"1487\">Oncological Outcomes of Stage IIIA Endometrioid Type Endometrial Cancer: Eine multizentrische Studie.<br data-start=\"1580\" data-end=\"1583\"> UHOD 29 (2): 088-096<\/p>\n<\/li><li><p data-start=\"1607\" data-end=\"1950\"><strong data-start=\"1607\" data-end=\"1722\">MEYDANLI, Mehmet Mutlu; ASLAN, Koray; &Ouml;Z, Murat; MUFTUOGLU, Kamil Hakan; YALCIN, Ibrahim; ENG&#304;N-USTUN, Yaprak (2019).<\/strong><br data-start=\"1722\" data-end=\"1725\">Ist es m&ouml;glich, ein Vorhersagemodell f&uuml;r die Invasion des lymphovaskul&auml;ren Raums bei endometrioidem Endometriumkarzinom zu entwickeln?<br data-start=\"1839\" data-end=\"1842\"><em data-start=\"1842\" data-end=\"1865\">Int J Gynecol Pathol.<\/em> 24. April 2019. doi: 10.1097\/PGP.0000000000000596. [Online-Ver&ouml;ffentlichung vor Drucklegung] PMID: 31033799<\/p>\n<\/li><li><p data-start=\"1952\" data-end=\"2451\"><strong data-start=\"1952\" data-end=\"2217\">BOYRAZ G&ouml;khan, DURMUS Yasin, C&#304;C&#304;N Irfan, KURU O&#287;uzhan, BOSTANCI Esra, COMERT G&uuml;nsu Kimyon, SAH&#304;N Hanifi, AY&#304;K H&uuml;lya, UREYEN I&#351;&#305;n, KARALOK Alper, MEYDANLI Mehmet Mutlu, SALMAN Mehmet Co&#351;kun, OZGUL Nejat, ONAN An&#305;l, S&#304;MSEK Tayup, YUCE Kunter, TURAN Taner (2019).<\/strong><br data-start=\"2217\" data-end=\"2220\">Prognostische Faktoren und onkologische Ergebnisse bei Ovarialtumoren des Dottersacks: eine retrospektive multizentrische Analyse von 99 F&auml;llen.<br data-start=\"2342\" data-end=\"2345\"><em data-start=\"2345\" data-end=\"2367\">Arch Gynecol Obstet.<\/em> 13. April 2019. doi: 10.1007\/s00404-019-05160-6. [Online-Ver&ouml;ffentlichung vor Drucklegung]. PMID: 30982145<\/p>\n<\/li><li><p data-start=\"2453\" data-end=\"2996\"><strong data-start=\"2453\" data-end=\"2731\">K&#304;MYON C&Ouml;MERT G&uuml;nsu, T&Uuml;RKMEN Osman, BOYRAZ G&ouml;khan, YAL&Ccedil;IN &#304;brahim, ALTIN Duygu, KARAL&Ouml;K Alper, &#350;AH&#304;N Hanifi, TA&#350;KIN Salih, BA&#350;ARAN Derman, FIRAT CUYLAN Zeliha, KOYUNCU K, SALMAN Mehmet Co&#351;kun, &Ouml;ZG&Uuml;L Nejat, MEYDANLI Mehmet Mutlu, TURAN Taner, ORTA&Ccedil; F&#305;rat, Y&Uuml;CE Kunter (2019).<\/strong><br data-start=\"2731\" data-end=\"2734\">Auswirkungen einer adjuvanten Therapie auf die onkologischen Ergebnisse bei chirurgisch best&auml;tigten Uteruskarzinosarkomen im Stadium I: Eine t&uuml;rkische gyn&auml;kologisch-onkologische Studie.<br data-start=\"2873\" data-end=\"2876\"><em data-start=\"2876\" data-end=\"2891\">Balkan Med J.<\/em> 36 (4): 229&ndash;234. doi: 10.4274\/balkanmedj.galenos.2019.2018.12.75. [Epub vor Drucklegung] (PMID: 30873825)<\/p>\n<\/li><li><p data-start=\"2998\" data-end=\"3308\"><strong data-start=\"2998\" data-end=\"3105\">AYHAN Ali, &#350;AH&#304;N Hanifi, SARI Mustafa Erkan, YAL&Ccedil;IN &#304;brahim, HABERAL Ali, MEYDANLI Mehmet Mutlu (2019).<\/strong><br data-start=\"3105\" data-end=\"3108\">Prognostische Bedeutung der Invasion des lymphovaskul&auml;ren Raums bei Endometriumkarzinomen mit geringem Risiko.<br data-start=\"3196\" data-end=\"3199\"><em data-start=\"3199\" data-end=\"3221\">Int J Gynecol Cancer<\/em> 29 (3): 505&ndash;512. doi: 10.1136\/ijgc-2018-000069. [Epub vor Drucklegung] (PMID: 30665899)<\/p>\n<\/li><li><p data-start=\"3310\" data-end=\"3738\"><strong data-start=\"3310\" data-end=\"3493\">&#350;AH&#304;N Hanifi, MEYDANLI Mehmet Mutlu, SARI Mustafa Erkan, KOCAMAN Eda, FIRAT C&Uuml;YLAN Zeliha, YAL&Ccedil;IN &#304;brahim, &Ccedil;OBAN Gonca, &Ouml;ZEN &Ouml;zlem, &#350;&#304;RVAN Levent, G&Uuml;NG&Ouml;R Tayfun, AYHAN Ali (2019).<\/strong><br data-start=\"3493\" data-end=\"3496\">Rezidivmuster und prognostische Faktoren bei endometrioidem Endometriumkarzinom mit Invasion des lymphovaskul&auml;ren Raums, das chirurgisch auf die Geb&auml;rmutter beschr&auml;nkt ist.<br data-start=\"3647\" data-end=\"3650\"><em data-start=\"3650\" data-end=\"3675\">Taiwan J Obstet Gynecol<\/em> 58(1):82&ndash;89. doi: 10.1016\/j.tjog.2018.11.016. (PMID: 30638487)<\/p>\n<\/li><li><p data-start=\"3740\" data-end=\"4140\"><strong data-start=\"3740\" data-end=\"3887\">SARI Mustafa Erkan, MEYDANLI Mehmet Mutlu, YAL&Ccedil;IN &#304;brahim, &#350;AH&#304;N Hanifi, &Ccedil;OBAN Gonca, &Ccedil;elik H&uuml;sn&uuml;, KU&#350;&Ccedil;U Esra, G&Uuml;NG&Ouml;R Tayfun, AYHAN Ali (2018).<\/strong><br data-start=\"3887\" data-end=\"3890\">Risikofaktoren f&uuml;r Lymphknotenmetastasen bei Frauen mit endometrioidem Endometriumkarzinom, das klinisch auf die Geb&auml;rmutter beschr&auml;nkt ist und eine Invasion des lymphovaskul&auml;ren Raums aufweist.<br data-start=\"4051\" data-end=\"4054\"><em data-start=\"4054\" data-end=\"4083\">Oncology Research Treatment<\/em> 41(12): 750&ndash;754. DOI:10.1159\/000492585. (PMID: 30419557)<\/p>\n<\/li><li><p data-start=\"4142\" data-end=\"4556\"><strong data-start=\"4142\" data-end=\"4385\">FIRAT C&Uuml;YLAN Zeliha, KARAB&Uuml;K Emine, &Ouml;Z Murat, TURAN Ahmet Taner, MEYDANLI Mehmet Mutlu, TA&#350;KIN Salih, SARI Mustafa Erkan, &#350;AH&#304;N Hanifi, ULUKENT Serhat Can, AKBAYIR &Ouml;zg&uuml;r, G&Uuml;NG&Ouml;RD&Uuml;K Kemal, G&Uuml;NG&Ouml;R Tayfun, K&Ouml;SE Mehmet Faruk, AYHAN Ali (2018).<\/strong><br data-start=\"4385\" data-end=\"4388\">Vergleich von muzin&ouml;sem und ser&ouml;sem Eierstockkrebs im Stadium III: eine Fall-Kontroll-Studie.<br data-start=\"4469\" data-end=\"4472\"><em data-start=\"4472\" data-end=\"4498\">Journal Ovarian Research<\/em> 11(1):91. DOI:10.1186\/s13048-018-0464-2. (PMID: 30376858)<\/p>\n<\/li><li><p data-start=\"4558\" data-end=\"4869\"><strong data-start=\"4558\" data-end=\"4672\">YAL&Ccedil;IN &#304;brahim, SARI Mustafa Erkan, &#350;AH&#304;N Hanifi, G&Uuml;LTEK&#304;N Murat, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu (2018).<\/strong><br data-start=\"4672\" data-end=\"4675\">Befunde der kolposkopischen Biopsie bei Frauen mit ausschlie&szlig;lich HPV-16 oder ausschlie&szlig;lich HPV-18 bei normalem zytologischem Befund.<br data-start=\"4779\" data-end=\"4782\"><em data-start=\"4782\" data-end=\"4834\">International Journal of Gynecology and Obstetrics<\/em> 143 (3): 300&ndash;305. (PMID: 30129141)<\/p>\n<\/li><li><p data-start=\"4871\" data-end=\"5322\"><strong data-start=\"4871\" data-end=\"5116\">&#350;AH&#304;N Hanifi, MEYDANLI Mehmet Mutlu, SARI Mustafa Erkan, YAL&Ccedil;IN &#304;brahim, &Ccedil;OBAN Gonca, TOPFEDA&#304;S&#304; &Ouml;ZKAN Nazl&#305;, FIRAT C&Uuml;YLAN Zeliha, ERDEM Baki, G&Uuml;NG&Ouml;RD&Uuml;K Kemal, AKBAYIR &Ouml;zg&uuml;r, DEDE Murat, SALMAN Mehmet Co&#351;kun, G&Uuml;NG&Ouml;R Tayfun, AYHAN Ali (2018).<\/strong><br data-start=\"5116\" data-end=\"5119\">Hat der prim&auml;re Ausbreitungsweg eine prognostische Bedeutung bei nicht-ser&ouml;sem epithelialem Eierstockkrebs im Stadium III?<br data-start=\"5233\" data-end=\"5236\"><em data-start=\"5236\" data-end=\"5265\">Journal of Ovarian Research<\/em> 11(1):21. doi: 10.1186\/s13048-018-0393-0 (PMID: 4325675)<\/p>\n<\/li><li><p data-start=\"5324\" data-end=\"5730\"><strong data-start=\"5324\" data-end=\"5553\">G&Uuml;NG&Ouml;RD&Uuml;K Kemal, FIRAT C&Uuml;YLAN Zeliha, KAHRAMANOGLU &#304;lker, &Ouml;GE Tufan, AKBAYIR &Ouml;zg&uuml;r, DEDE Murat, TA&#350;KIN Salih, &Ouml;ZG&Uuml;L Nejat, &#350;&#304;MSEK Tayup, TURAN Hasan, G&Uuml;LSEREN Varol, &Ouml;ZDEM&#304;R &#304;sa Aykut, MEYDANLI Mehmet Mutlu, AYHAN Ali (2018).<\/strong><br data-start=\"5553\" data-end=\"5556\">Risikofaktoren f&uuml;r ein Rezidiv bei Endometriumkarzinomen mit geringem Risiko: Eine Fall-Kontroll-Studie.<br data-start=\"5637\" data-end=\"5640\"><em data-start=\"5640\" data-end=\"5673\">Oncology Research and Treatment<\/em> 41(7-8): 466-470. DOI: 10.1159\/000488112 (PMID: 4325651)<\/p>\n<\/li><li><p data-start=\"5732\" data-end=\"6200\"><strong data-start=\"5732\" data-end=\"5933\">FIRAT C&Uuml;YLAN Zeliha, MEYDANLI Mehmet Mutlu, SARI Mustafa Erkan, AKBAYIR &Ouml;zg&uuml;r, &Ccedil;EL&#304;K H&uuml;sn&uuml;, DEDE Murat, &#350;AH&#304;N Hanifi, G&Uuml;NG&Ouml;RD&Uuml;K Kemal, KU&#350;&Ccedil;U &Uuml;lk&uuml; Esra, &Ouml;ZG&Uuml;L Nejat, G&Uuml;NG&Ouml;R Tayfun, AYHAN Ali (2018).<\/strong><br data-start=\"5933\" data-end=\"5936\">Prognostische Faktoren f&uuml;r maximal oder optimal zytoreduzierte nicht-ser&ouml;se epitheliale Ovarialkarzinome im Stadium III, die mit einer Carboplatin\/Paclitaxel-Chemotherapie behandelt wurden.<br data-start=\"6092\" data-end=\"6095\"><em data-start=\"6095\" data-end=\"6143\">Journal of Obstetrics and Gynaecology Research<\/em> 44(7): 1284&ndash;1293. doi: 10.1111\/jog.13663 (PMID: 4325669)<\/p>\n<\/li><li><p data-start=\"6202\" data-end=\"6680\"><strong data-start=\"6202\" data-end=\"6427\">FIRAT C&Uuml;YLAN Zeliha, &Ouml;Z Murat, TOPFEDA&#304;S&#304; &Ouml;ZKAN Nazl&#305;, K&#304;MYON C&Ouml;MERT G&uuml;nsu, &#350;AH&#304;N Hanifi, TURAN Ahmet Taner, AKBAYIR &Ouml;zg&uuml;r, KU&#350;&Ccedil;U &Uuml;lk&uuml; Esra, &Ccedil;EL&#304;K H&uuml;sn&uuml;, DEDE Murat, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu, AYHAN Ali (2018).<\/strong><br data-start=\"6427\" data-end=\"6430\">Prognostische Faktoren und Rezidivmuster bei Frauen mit endometrioidem Endometriumkarzinom im Stadium IIIC und positiver Invasion des lymphovaskul&auml;ren Raums.<br data-start=\"6572\" data-end=\"6575\"><em data-start=\"6575\" data-end=\"6623\">Journal of Obstetrics and Gynaecology Research<\/em> 44(6): 1140&ndash;1149. doi: 10.1111\/jog.13615 (PMID: 4325672)<\/p>\n<\/li><li><p data-start=\"6682\" data-end=\"6978\"><strong data-start=\"6682\" data-end=\"6783\">&Ouml;ZDAL B&uuml;lent, &Ouml;Z Murat, YAL&Ccedil;IN Hakan, &#350;&#304;RVAN Levent, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu (2018).<\/strong><br data-start=\"6783\" data-end=\"6786\">Isolierte para-aortale Lymphknotenmetastasen bei Endometriumkarzinom vom Typ Endometrioid im vollst&auml;ndigen Stadium.<br data-start=\"6887\" data-end=\"6890\"><em data-start=\"6890\" data-end=\"6933\">European Journal of Gynaecologic Oncology<\/em> 39 (2): 205-209. doi: 10.12892\/ejgo3862.2018 <\/p>\n<\/li><li><p data-start=\"6980\" data-end=\"7389\"><strong data-start=\"6980\" data-end=\"7173\">&#350;AH&#304;N Hanifi, SARI Mustafa Erkan, FIRAT C&Uuml;YLAN Zeliha, HABERAL Asuman Nihan, &#350;&#304;RVAN Levent, &Ccedil;OBAN Gonca, YAL&Ccedil;IN &#304;brahim, G&Uuml;NG&Ouml;R Tayfun, &Ccedil;EL&#304;K H&uuml;sn&uuml;, MEYDANLI Mehmet Mutlu, AYHAN Ali (2018).<\/strong><br data-start=\"7173\" data-end=\"7176\">Ist das Vorliegen einer Endometriose mit einem &Uuml;berlebensvorteil bei reinem klarzelligem Ovarialkarzinom verbunden?<br data-start=\"7281\" data-end=\"7284\"><em data-start=\"7284\" data-end=\"7323\">Archives of Gynecology and Obstetrics<\/em> 297(4): 1005&ndash;1013. doi: 10.1007\/s00404-018-4651-6 (PMID: 4325676)<\/p>\n<\/li><li><p data-start=\"7391\" data-end=\"7773\"><strong data-start=\"7391\" data-end=\"7519\">YAL&Ccedil;IN &#304;brahim, MEYDANLI Mehmet Mutlu, TURAN Ahmet Taner, TA&#350;KIN Salih, SARI Mustafa Erkan, G&Uuml;NG&Ouml;R Tayfun, AYHAN Ali (2018).<\/strong><br data-start=\"7519\" data-end=\"7522\">Karzinosarkom des Eierstocks im Vergleich zum hochgradigen ser&ouml;sen Ovarialkarzinom: Auswirkungen einer optimalen zytoreduktiven Resektion und einer standardm&auml;&szlig;igen adjuvanten Therapie.<br data-start=\"7663\" data-end=\"7666\"><em data-start=\"7666\" data-end=\"7710\">International Journal of Clinical Oncology<\/em> 23(2): 329&ndash;337. doi: 10.1007\/s10147-017-1215-x (PMID: 4325679)<\/p>\n<\/li><li><p data-start=\"7775\" data-end=\"8276\"><strong data-start=\"7775\" data-end=\"8056\">AYHAN Ali, TOPFEDA&#304;S&#304; &Ouml;ZKAN Nazl&#305;, &Ouml;Z Murat, K&#304;MYON C&Ouml;MERT G&uuml;nsu, FIRAT C&Uuml;YLAN Zeliha, &Ccedil;OBAN Gonca, T&Uuml;RKMEN Osman, ERDEM Baki, &#350;AH&#304;N Hanifi, AKBAYIR &Ouml;zg&uuml;r, DEDE Murat, TURAN Ahmet Taner, &Ccedil;EL&#304;K H&uuml;sn&uuml;, G&uuml;ng&ouml;r Tayfun, HABERAL Ali, ARVAS Mehmet Macit, MEYDANLI Mehmet Mutlu (2018).<\/strong><br data-start=\"8056\" data-end=\"8059\">Einfluss des Lymphknotenverh&auml;ltnisses auf das &Uuml;berleben bei endometrioidem Endometriumkarzinom im Stadium IIIC: eine Studie der Turkish Gynecologic Oncology Group.<br data-start=\"8188\" data-end=\"8191\"><em data-start=\"8191\" data-end=\"8224\">Journal of Gynecologic Oncology<\/em> 29(4), doi: 10.3802\/jgo.2018.29.e48 (PMID: 4325667)<\/p>\n<\/li><li><p data-start=\"8278\" data-end=\"8705\"><strong data-start=\"8278\" data-end=\"8485\">AYHAN Ali, TOPFEDA&#304;S&#304; &Ouml;ZKAN Nazl&#305;, SARI Mustafa Erkan, &Ccedil;EL&#304;K H&uuml;sn&uuml;, DEDE Murat, AKBAYIR &Ouml;zg&uuml;r, G&Uuml;NG&Ouml;RD&Uuml;K Kemal, &#350;AH&#304;N Hanifi, HABERAL Ali, G&uuml;ng&ouml;r Tayfun, ARVAS Mehmet Macit, MEYDANLI Mehmet Mutlu (2018).<\/strong><br data-start=\"8485\" data-end=\"8488\">Einfluss des Lymphknotenverh&auml;ltnisses auf das &Uuml;berleben bei hochgradigem ser&ouml;sem Eierstockkrebs im Stadium III: eine Studie der Turkish Gynecologic Oncology Group.<br data-start=\"8617\" data-end=\"8620\"><em data-start=\"8620\" data-end=\"8653\">Journal of Gynecologic Oncology<\/em> 29(1), doi: 10.3802\/jgo.2018.29.e12 (PMID: 4325678)<\/p>\n<\/li><li><p data-start=\"8707\" data-end=\"9267\"><strong data-start=\"8707\" data-end=\"9029\">BOYRAZ G&ouml;khan, SALMAN Mehmet Co&#351;kun, G&Uuml;LTEK&#304;N Murat, TOPFEDA&#304;S&#304; &Ouml;ZKAN Nazl&#305;, U&Ccedil;KAN Hasan, G&Uuml;NG&Ouml;RD&Uuml;K Kemal, G&Uuml;LSEREN Varol, AYIK H&uuml;lya, TOPTA&#350; Tayfun, KURU O&#287;uzhan, S&Ouml;ZEN H, ERT&Uuml;RK An&#305;l, &Ouml;ZG&Uuml;L Nejat, MEYDANLI Mehmet Mutlu, SANCI Muzaffer, TURAN Ahmet Taner, G&Uuml;NG&Ouml;R Tayfun, &#350;&#304;M&#350;EK Tayup, TOPUZ Samet, Y&Uuml;CE Kunter (2017).<\/strong><br data-start=\"9029\" data-end=\"9032\">Welchen Einfluss hat die stromale Mikroinvasion auf die onkologischen Ergebnisse bei Borderline-Ovarialtumoren? Eine multizentrische Fall-Kontroll-Studie. <br data-start=\"9161\" data-end=\"9164\"><em data-start=\"9164\" data-end=\"9203\">Archives of Gynecology and Obstetrics<\/em> 296(5): 979-987. doi: 10.1007\/s00404-017-4496-4 (PMID: 3783685)<\/p>\n<\/li><li><p data-start=\"9269\" data-end=\"9552\"><strong data-start=\"9269\" data-end=\"9367\">SARI Mustafa Erkan, YAL&Ccedil;IN &#304;brahim, &#350;AH&#304;N Hanifi, MEYDANLI Mehmet Mutlu, G&Uuml;NG&Ouml;R Tayfun (2017).<\/strong><br data-start=\"9367\" data-end=\"9370\">Risikofaktoren f&uuml;r paraaortale Lymphknotenmetastasen bei Endometriumkarzinom.<br data-start=\"9442\" data-end=\"9445\"><em data-start=\"9445\" data-end=\"9489\">International Journal of Clinical Oncology<\/em> 22(5): 937&ndash;944. doi: 10.1007\/s10147-017-1139-5 (PMID: 3608468)<\/p>\n<\/li><li><p data-start=\"9554\" data-end=\"9906\"><strong data-start=\"9554\" data-end=\"9689\">&Ouml;Z Murat, KARAL&Ouml;K Alper, &#350;&#304;RVAN Levent, TA&#350;&Ccedil;I Tolga, &Ouml;CALAN Reyhan, TURAN Ahmet Taner, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu (2017).<\/strong><br data-start=\"9689\" data-end=\"9692\">Vanishing-Endometriumkarzinom in Hysterektomiepr&auml;paraten: m&ouml;gliche Implikationen f&uuml;r die fruchtbarkeitserhaltende Behandlung.<br data-start=\"9806\" data-end=\"9809\"><em data-start=\"9809\" data-end=\"9846\">Turkish Journal of Medical Sciences<\/em> 47 (6): 1744&ndash;1750. doi: 10.3906\/sag-1607-93 (PMID: 3708984)<\/p>\n<\/li><li><p data-start=\"9908\" data-end=\"10207\"><strong data-start=\"9908\" data-end=\"10001\">SARI Mustafa Erkan, KORKMAZ Elmas, &Ouml;Z Murat, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu (2017).<\/strong><br data-start=\"10001\" data-end=\"10004\">Risikofaktoren f&uuml;r eine Blinddarmbeteiligung bei Frauen mit epithelialem Eierstockkrebs.<br data-start=\"10085\" data-end=\"10088\"><em data-start=\"10088\" data-end=\"10145\">Zeitschrift der T&uuml;rkisch-Deutschen Gesellschaft f&uuml;r Gyn&auml;kologie<\/em> 18 (3): 116&ndash;121. doi: 10.4274\/jtgga.2017.0005 (PMID: 3608466)<\/p>\n<\/li><li><p data-start=\"10209\" data-end=\"10811\"><strong data-start=\"10209\" data-end=\"10590\">G&Uuml;NG&Ouml;RD&Uuml;K Kemal, &Ouml;ZDEM&#304;R &#304;sa Aykut, SELCUK &#304;lker, TELL&#304; Elcin, &Ouml;ZT&Uuml;RK &#350;ahin, TOPTA&#350; Tayfun, AKMAN Levent, G&Uuml;ZEL Ahmet Bar&#305;&#351;, TA&#350;KIN Salih, &Ouml;GE Tufan, G&Uuml;NG&Ouml;RD&Uuml;K &Ouml;zg&uuml;, G&Ouml;K&Ccedil;&Uuml; Mehmet, G&Uuml;NG&Ouml;R Tayfun, YA&#350;AR Levent, TEREK Mustafa Co&#351;an, OZAN Hakan, &Ouml;ZSARAN Ahmet Ayd&#305;n, SANCI Muzaffer, VARDAR Mehmet Ali, MEYDANLI Mehmet Mutlu, YAL&Ccedil;IN &Ouml;mer Tar&#305;k, ORTA&Ccedil; U&#287;ur F&#305;rat, &Ouml;ZALP Sinan (2017).<\/strong><br data-start=\"10590\" data-end=\"10593\">Vergleich von hochgradigen ser&ouml;sen Prim&auml;rtumoren der Eileiter im Fr&uuml;hstadium und epithelialen Ovarialkarzinomen: Eine multizentrische Studie.<br data-start=\"10720\" data-end=\"10723\"><em data-start=\"10723\" data-end=\"10756\">Oncology Research and Treatment<\/em> 40(4): 203&ndash;206. doi: 10.1159\/000458440 (PMID: 3627063)<\/p>\n<\/li>\n \t<li data-start=\"3997\" data-end=\"4371\">\n<p data-start=\"67\" data-end=\"371\"><strong data-start=\"67\" data-end=\"176\">Erkaya Salim, &Ouml;z Murat, Top&ccedil;u Hasan Onur, &#350;irvan Ali Levent, G&uuml;ng&ouml;r Tayfun, Meydanl&#305; Mehmet Mutlu (2017).<\/strong><br data-start=\"176\" data-end=\"179\">Is lower uterine segment involvement a prognostic factor in endometrial cancer?<br data-start=\"258\" data-end=\"261\"><em data-start=\"261\" data-end=\"298\">Turkish Journal of Medical Sciences<\/em>, 47(1), 300-306.<br data-start=\"315\" data-end=\"318\">Doi: 10.3906\/sag-1602-137<br data-start=\"343\" data-end=\"346\">(Publication No: 3708891)<\/p>\n\n\n\n<\/li><li><p data-start=\"378\" data-end=\"898\"><strong data-start=\"378\" data-end=\"640\">Boyraz G&ouml;khan, Salman Mehmet Co&#351;kun, Ba&#351;aran Derman, &Ouml;zg&uuml;l Nejat, Turan Taner, T&uuml;rkmen Osman, C&ouml;mert Kimyon G&uuml;ns&uuml;, Topfedaisi &Ouml;zkan Nazl&#305;, &Ccedil;a&#287;an Murat, G&uuml;ng&ouml;r Tayfun, Meydanl&#305; Mehmet Mutlu, G&uuml;ng&ouml;rd&uuml;k Kemal, G&uuml;lseren Varol, Sanc&#305; Muzaffer, Y&uuml;ce Kunter (2017).<\/strong><br data-start=\"640\" data-end=\"643\">Extrauterine Ausbreitung, adjuvante Behandlung und Prognose bei nichtinvasivem papill&auml;r-ser&ouml;sem Karzinom der Geb&auml;rmutterschleimhaut.<br data-start=\"767\" data-end=\"770\"><em data-start=\"770\" data-end=\"817\">International Journal of Gynecological Cancer<\/em>, 27(1), 102-108.<br data-start=\"834\" data-end=\"837\">Doi: 10.1097\/IGC.0000000000000838<br data-start=\"870\" data-end=\"873\">(Ver&ouml;ffentlichungsnummer: 3570647)<\/p>\n\n\n\n<\/li><li><p data-start=\"905\" data-end=\"1616\"><strong data-start=\"905\" data-end=\"1427\">G&uuml;ng&ouml;rd&uuml;k Kemal, A&#351;icio&#287;lu Osman, Bracu Elena Iona, Almuheimid Jumana, G&ouml;kulu &#350;evki G&ouml;ksun, &Ccedil;etinkaya Nil&uuml;fer, G&uuml;ng&ouml;r Tayfun, Pakay Gonca, Telli &Uuml;zmez El&ccedil;in, F&#305;rat C&uuml;ylan Zeliha, Topta&#351; Tayfun, Bilgi Ahmet, &Ouml;zyurt Ramazan, A&#287;a&ccedil;ayak Elif, Erol Onur, Turan An&#305;l, &#304;&ccedil;en Mehmet Sait, &#350;enol Taylan, Ovali &Ouml;zlem Irak, Y&uuml;cesoy Burcu, G&uuml;ng&ouml;rd&uuml;k &Ouml;zg&uuml;, Sanc&#305; Muzaffer, &#350;im&#351;ek Tayup, Meydanl&#305; Mehmet Mutlu, Harma Mehmet &#304;brahim, Uysal Demerbent Aysel, Karateke Ate&#351;, &Ouml;zalp Sinan Sabit, Sehouli Jalid, Muallem Mustafa Zelal (2017).<\/strong><br data-start=\"1427\" data-end=\"1430\">Der Einfluss des chirurgischen Stagings auf die Prognose von muzin&ouml;sen Borderline-Tumoren der Eierst&ouml;cke: A Multicenter Study.<br data-start=\"1544\" data-end=\"1547\"><em data-start=\"1547\" data-end=\"1568\">Anticancer Research<\/em>, 37(10), 5609-5616.<br data-start=\"1588\" data-end=\"1591\">(Publikationsnummer: 3602353)<\/p>\n\n\n\n<\/li><li><p data-start=\"1623\" data-end=\"2017\"><strong data-start=\"1623\" data-end=\"1738\">&Ouml;z Murat, Korkmaz Vakkas, Meydanl&#305; Mehmet Mutlu, Sar&#305; Mustafa Erkan, F&#305;rat C&uuml;ylan Zeliha, G&uuml;ng&ouml;r Tayfun (2017).<\/strong><br data-start=\"1738\" data-end=\"1741\">Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion?<br data-start=\"1884\" data-end=\"1887\"><em data-start=\"1887\" data-end=\"1934\">International Journal of Gynecological Cancer<\/em>, 27(7), 1393-1398.<br data-start=\"1953\" data-end=\"1956\">Doi: 10.1097\/IGC.0000000000001025<br data-start=\"1989\" data-end=\"1992\">(Ver&ouml;ffentlichungsnummer: 3608469)<\/p>\n<\/li><li><p data-start=\"2024\" data-end=\"2760\"><strong data-start=\"2024\" data-end=\"2535\">Topfedaisi &Ouml;zkan Nazl&#305;, Meydanl&#305; Mehmet Mutlu, Sar&#305; Mustafa Erkan, Demirk&#305;ran Fuat, Kahramano&#287;lu &#304;lker, Be&#351;e Tevfik Tugan, Arvas Mehmet Macit, &#350;ahin Hanifi, Haberal Ali, &Ccedil;elik H&uuml;sn&uuml;, &Ccedil;oban Gonca, &Ouml;ge Tufan, Yal&ccedil;&#305;n &Ouml;mer Tar&#305;k, Akbay&#305;r &Ouml;zg&uuml;r, Erdem Baki, Numano&#287;lu Ceyhun, &Ouml;zg&uuml;l Nejat, Boyraz G&ouml;khan, Salman Mehmet Co&#351;kun, Y&uuml;ce Kunter, Dede Murat, Yenen M&uuml;fit Cemal, Ta&#351;k&#305;n Salih, Alt&#305;n Duygu, Orta&ccedil; U&#287;ur F&#305;rat, Ayd&#305;n Ay&#305;k H&uuml;lya, &#350;im&#351;ek Tayup, G&uuml;ng&ouml;r Tayfun, G&uuml;ng&ouml;rd&uuml;k Kemal, Sanc&#305; Muzaffer, Ayhan Ali (2017).<\/strong><br data-start=\"2535\" data-end=\"2538\">Faktoren, die mit dem &Uuml;berleben nach einem Rezidiv bei Patientinnen mit Endometriumkarzinom mit geringem Risiko, das allein durch eine Operation behandelt wurde, in Verbindung stehen.<br data-start=\"2657\" data-end=\"2660\"><em data-start=\"2660\" data-end=\"2693\">Journal of Gynecologic Oncology<\/em>, 28(5),<br data-start=\"2701\" data-end=\"2704\">Doi: 10.3802\/jgo.2017.28.e65<br data-start=\"2732\" data-end=\"2735\">(Publication No: 3608472)<\/p>\n<\/li><li><p data-start=\"2767\" data-end=\"3278\"><strong data-start=\"2767\" data-end=\"3092\">&Ouml;zg&uuml;l Nejat, Boyraz G&ouml;khan, Salman Mehmet Co&#351;kun, G&uuml;ltekin Murat, Y&uuml;ce Kunter, &#304;brahimov Akbar, Ert&uuml;rk An&#305;l, G&uuml;ng&ouml;rd&uuml;k Kemal, G&uuml;lseren Varol, Sanc&#305; Muzaffer, T&uuml;rkmen Osman, Karal&ouml;k Alper, Kimyon G&uuml;nsu, Turan Ahmet Taner, Topfedaisi &Ouml;zkan Nazl&#305;, Meydanl&#305; Mehmet Mutlu, G&uuml;ng&ouml;r Tayfun, Ay&#305;k Ayd&#305;n H&uuml;lya, &#350;im&#351;ek Tayup (2017).<\/strong><br data-start=\"3092\" data-end=\"3095\">Oncological Outcomes of Stage II Endometrial Cancer.<br data-start=\"3147\" data-end=\"3150\"><em data-start=\"3150\" data-end=\"3197\">International Journal of Gynecological Cancer<\/em>, 28(1), 161-167.<br data-start=\"3214\" data-end=\"3217\">Doi: 10.1097\/IGC.0000000000001133<br data-start=\"3250\" data-end=\"3253\">(Ver&ouml;ffentlichungsnummer: 3608475)<\/p>\n<\/li><li><p data-start=\"3285\" data-end=\"3559\">&Ccedil;etinkaya <strong data-start=\"3285\" data-end=\"3380\">Nil&uuml;fer, Sel&ccedil;uk &#304;lker, &Ouml;zdal B&uuml;lent, Meydanl&#305; Mehmet Mutlu, G&uuml;ng&ouml;r Tayfun (2017).<\/strong><br data-start=\"3380\" data-end=\"3383\">Prognostic factors in endometrial clear cell carcinoma.<br data-start=\"3438\" data-end=\"3441\"><em data-start=\"3441\" data-end=\"3480\">Archives of Gynecology and Obstetrics<\/em>, 295(1), 189-195.<br data-start=\"3498\" data-end=\"3501\">Doi: 10.1007\/s00404-016-4183-X<br data-start=\"3531\" data-end=\"3534\">(Publikationsnummer: 3493260)<\/p>\n<\/li><li><p data-start=\"3566\" data-end=\"4255\"><strong data-start=\"3566\" data-end=\"4000\">Sar&#305; Mustafa Erkan, Meydanl&#305; Mehmet Mutlu, T&uuml;rkmen Osman, C&ouml;mert Kimyon G&uuml;nsu, Turan Ahmet Taner, Karalok Alper, &#350;ahin Hanifi, Haberal Ali, Kocaman Eda, Akbay&#305;r &Ouml;zg&uuml;r, Erdem Baki, Numano&#287;lu Ceyhun, G&uuml;ng&ouml;rd&uuml;k Kemal, Sanc&#305; Muzaffer, G&ouml;kc&uuml; Mehmet, &Ouml;zg&uuml;l Nejat, Salman Mehmet Co&#351;kun, Boyraz G&ouml;khan, Y&uuml;ce Kunter, G&uuml;ng&ouml;r Tayfun, Ta&#351;k&#305;n Salih, Alt&#305;n Duygu, Orta&ccedil; U&#287;ur F&#305;rat, Ay&#305;k Ayd&#305;n H&uuml;lya, &#350;im&#351;ek Tayup, Arvas Macit, Ayhan Ali (2017).<\/strong><br data-start=\"4000\" data-end=\"4003\">Prognostische Faktoren und Behandlungsergebnisse bei chirurgisch behandeltem nicht-invasivem Klarzellkarzinom der Geb&auml;rmutter: eine Studie der Turkish Gynecologic Oncology Group.<br data-start=\"4152\" data-end=\"4155\"><em data-start=\"4155\" data-end=\"4188\">Journal of Gynecologic Oncology<\/em>, 28(4),<br data-start=\"4196\" data-end=\"4199\">Doi: 10.3802\/jgo.2017.28.e49<br data-start=\"4227\" data-end=\"4230\">(Ver&ouml;ffentlichungsnummer: 3941957)<\/p>\n<\/li><li><p data-start=\"4262\" data-end=\"4697\"><strong data-start=\"4262\" data-end=\"4427\">Korkmaz Vakkas, Meydanl&#305; Mehmet Mutlu, Yal&ccedil;&#305;n &#304;brahim, Sar&#305; Mustafa Erkan, &#350;ahin Hanifi, Kocaman Eda, Haberal Ali, Dursun Polat, G&uuml;ng&ouml;r Tayfun, Ayhan Ali (2017).<\/strong><br data-start=\"4427\" data-end=\"4430\">Vergleich von drei verschiedenen Risikostratifizierungsmodellen zur Vorhersage des Lymphknotenbefalls bei klinisch auf den Uterus begrenztem endometrioidem Endometriumkarzinom.<br data-start=\"4594\" data-end=\"4597\"><em data-start=\"4597\" data-end=\"4630\">Journal of Gynecologic Oncology<\/em>, 28(6),<br data-start=\"4638\" data-end=\"4641\">Doi: 10.3802\/jgo.2017.28.e78<br data-start=\"4669\" data-end=\"4672\">(Ver&ouml;ffentlichungsnummer: 3942145)<\/p>\n<\/li><li><p data-start=\"4704\" data-end=\"5415\"><strong data-start=\"4704\" data-end=\"5208\">G&ouml;k&ccedil;&uuml; Mehmet, G&uuml;ng&ouml;rd&uuml;k Kemal, A&#351;icio&#287;lu Osman, &Ccedil;etinkaya Nil&uuml;fer, G&uuml;ng&ouml;r Tayfun, Pakay Gonca, F&#305;rat C&uuml;ylan Zeliha, Topta&#351; Tayfun, &Ouml;zyurt Ramazan, &Ouml;zdemir Aykut, Erol Onur, Turan An&#305;l, G&uuml;lseren Varol, &#350;enol Taylan, G&uuml;raslan Hakan, A&#287;a&ccedil;ayak Elif, &#304;&ccedil;en Mehmet Sait, Y&uuml;cesoy Burcu, &#350;ahbaz Ahmet, G&uuml;ng&ouml;rd&uuml;k &Ouml;zg&uuml;, Besimo&#287;lu Berhan, Pakay Kaan, Temizkan Osman, Sanc&#305; Muzaffer, &#350;im&#351;ek Tayup, Meydanl&#305; Mehmet Mutlu, Harma Mehmet &#304;brahim, Ya&#351;ar Levent, Birtan Boran, Derbent Uysal Aysel, Karateke Ate&#351; (2016).<\/strong><br data-start=\"5208\" data-end=\"5211\">Borderline-Ovarialtumoren: klinische Merkmale, Behandlung und Ergebnisse - eine multizentrische Studie.<br data-start=\"5311\" data-end=\"5314\"><em data-start=\"5314\" data-end=\"5343\">Journal of Ovarian Research<\/em>, 9(1), 66.<br data-start=\"5354\" data-end=\"5357\">Doi: 10.1186\/s13048-016-0276-1<br data-start=\"5387\" data-end=\"5390\">(Publikationsnummer: 3608461)<\/p>\n<\/li><li><p data-start=\"5422\" data-end=\"5732\"><strong data-start=\"5422\" data-end=\"5554\">&Ouml;zg&uuml; Emre, Narin Mehmet Ali, Yal&ccedil;&#305;n Hakan Ra&#351;it, Ta&#351;&ccedil;&#305; Tolga, G&uuml;ng&ouml;r Tayfun, Tulunay Hakk&#305; G&ouml;khan, Meydanl&#305; Mehmet Mutlu (2016).<\/strong><br data-start=\"5554\" data-end=\"5557\">Uterine Adenosarkome: A dual-institution experience.<br data-start=\"5610\" data-end=\"5613\"><em data-start=\"5613\" data-end=\"5652\">Journal of Obstetrics and Gynaecology<\/em>, 37(1), 93-96.<br data-start=\"5667\" data-end=\"5670\">Doi: 10.1080\/01443615.2016.1228619<br data-start=\"5704\" data-end=\"5707\">(Publication No: 3493214)<\/p>\n<\/li><li><p data-start=\"5739\" data-end=\"6121\"><strong data-start=\"5739\" data-end=\"5850\">&Ouml;z Murat, &Ccedil;etinkaya Nil&uuml;fer, Korkmaz Elmas, Se&ccedil;kin Kerem Do&#287;a, Meydanl&#305; Mehmet Mutlu, G&uuml;ng&ouml;r Tayfun (2016).<\/strong><br data-start=\"5850\" data-end=\"5853\">Optimal cone size to predict positive surgical margins after cold knife conization (CKC) and the risk factors for residual disease.<br data-start=\"5984\" data-end=\"5987\"><em data-start=\"5987\" data-end=\"6044\">Journal of the Turkish German Gynecological Association<\/em>, 17(3), 159-162.<br data-start=\"6061\" data-end=\"6064\">Doi: 10.5152\/jtgga.2016.16066<br data-start=\"6093\" data-end=\"6096\">(Ver&ouml;ffentlichungsnummer: 3493235)<\/p>\n<\/li><li><p data-start=\"6128\" data-end=\"6696\"><strong data-start=\"6128\" data-end=\"6469\">Arvas Mehmet Macit, Saliho&#287;lu Mehmet Yavuz, &#350;al Veysel, G&uuml;ng&ouml;r Tayfun, S&ouml;zen Hamdullah, Kahramano&#287;lu &#304;lker, Topuz Samet, Demirk&#305;ran Fuat, &#304;yibozkurt Ahmet Cem, Be&#351;e Tevfik Tugan, Salman &Ouml;zg&uuml; Bur&ccedil;in, Vatansever Do&#287;an, Tokg&ouml;zo&#287;lu Nedim, Berkman Sinan, Turan Hasan, Bengisu Ergin, Sofiyeva Nigar, Demiral &#304;rem, Meydanl&#305; Mehmet Mutlu (2016).<\/strong><br data-start=\"6469\" data-end=\"6472\">Terti&auml;re Zytoreduktion bei rezidivierendem epithelialen Eierstockkrebs: eine multizentrische Studie in der T&uuml;rkei.<br data-start=\"6566\" data-end=\"6569\"><em data-start=\"6569\" data-end=\"6613\">Asian Pacific Journal of Cancer Prevention<\/em>, 17(4), 1909-1915.<br data-start=\"6632\" data-end=\"6635\">Doi: 10.7314\/APJCP.2016.17.4.1909<br data-start=\"6668\" data-end=\"6671\">(Ver&ouml;ffentlichungsnummer: 3608452)<\/p>\n<\/li><li><p data-start=\"6703\" data-end=\"7044\"><strong data-start=\"6703\" data-end=\"6798\">&Ccedil;etinkaya Nil&uuml;fer, Sel&ccedil;uk &#304;lker, &Ouml;zdal B&uuml;lent, Meydanl&#305; Mehmet Mutlu, G&uuml;ng&ouml;r Tayfun (2016).<\/strong><br data-start=\"6798\" data-end=\"6801\">Diagnostische Auswirkungen von Serum-CA-125-Spiegeln, Pap-Abstrich-Auswertung und Endometriumprobenentnahme bei Frauen mit endometrialem Klarzellkarzinom.<br data-start=\"6938\" data-end=\"6941\"><em data-start=\"6941\" data-end=\"6974\">Oncology Research and Treatment<\/em>, 39(5), 283-288.<br data-start=\"6991\" data-end=\"6994\">Doi: 10.1159\/000445860<br data-start=\"7016\" data-end=\"7019\">(Publication No: 3493281)<\/p>\n<\/li><li><p data-start=\"7051\" data-end=\"7521\"><strong data-start=\"7051\" data-end=\"7272\">G&uuml;ng&ouml;rd&uuml;k Kemal, &Ouml;zdemir Aykut, Erta&#351; &#304;brahim Egemen, Sel&ccedil;uk &#304;lker, Solmaz Ula&#351;, &Ouml;zg&uuml; Emre, Mat Emre, G&ouml;kc&uuml; Mehmet, Karadeniz Tuba, Akbay Serap, Sanc&#305; Muzaffer, Meydanl&#305; Mehmet Mutlu, Ayaz Duygu, G&uuml;ng&ouml;r Tayfun (2015).<\/strong><br data-start=\"7272\" data-end=\"7275\">Ist das muzin&ouml;se Adenokarzinom des Endometriums ein Risikofaktor f&uuml;r Lymphknotenbefall? Eine multizentrische Fall-Kontroll-Studie. <br data-start=\"7396\" data-end=\"7399\"><em data-start=\"7399\" data-end=\"7443\">International Journal of Clinical Oncology<\/em>, 20(4), 782-789.<br data-start=\"7460\" data-end=\"7463\">Doi: 10.1007\/s10147-014-0767-2<br data-start=\"7493\" data-end=\"7496\">(Publikationsnummer: 3608447)<\/p>\n<\/li><li><p data-start=\"7528\" data-end=\"7865\"><strong data-start=\"7528\" data-end=\"7645\">&Ouml;z Murat, Korkmaz Elmas, &Ccedil;etinkaya Nil&uuml;fer, Ba&#351; Sevda, &Ouml;zdal B&uuml;lent, Meydanl&#305; Mehmet Mutlu, G&uuml;ng&ouml;r Tayfun (2015).<\/strong><br data-start=\"7645\" data-end=\"7648\">Comparison of Topical Lidocaine Spray With Placebo for Pain Relief in Colposcopic Procedures.<br data-start=\"7741\" data-end=\"7744\"><em data-start=\"7744\" data-end=\"7784\">Journal of Lower Genital Tract Disease<\/em>, 19(3), 212-214.<br data-start=\"7801\" data-end=\"7804\">Doi: 10.1097\/LGT.0000000000000099<br data-start=\"7837\" data-end=\"7840\">(Publication No: 3493292)<\/p>\n<\/li><li><p data-start=\"7872\" data-end=\"8172\"><strong data-start=\"7872\" data-end=\"7978\">T&uuml;rk&ccedil;&uuml;o&#287;lu Ilg&#305;n, Kafkasl&#305; Ay&#351;e, Meydanl&#305; Mehmet Mutlu, &Ouml;zyal&#305;n Fatma, Ta&#351;kapan Mehmet &Ccedil;a&#287;atay (2011).<\/strong><br data-start=\"7978\" data-end=\"7981\">Unabh&auml;ngige Pr&auml;diktoren f&uuml;r das kardiovaskul&auml;re Risiko beim polyzystischen Ovarialsyndrom.<br data-start=\"8058\" data-end=\"8061\"><em data-start=\"8061\" data-end=\"8090\">Gynecological Endocrinology<\/em>, 27(11), 915-919.<br data-start=\"8108\" data-end=\"8111\">Doi: 10.3109\/09513590.2010.551566<br data-start=\"8144\" data-end=\"8147\">(Publication No: 3493346)<\/p>\n<\/li><li><p data-start=\"8179\" data-end=\"8582\"><strong data-start=\"8179\" data-end=\"8306\">T&uuml;rk&ccedil;&uuml;o&#287;lu Ilg&#305;n, &Uuml;st&uuml;n Yaprak, Turan Fahri, Kal&#305; Zercan, Bay Karabulut Aysun, Meydanl&#305; Mehmet Mutlu, Kafkasl&#305; Ay&#351;e (2010).<\/strong><br data-start=\"8306\" data-end=\"8309\">Bewertung des asymmetrischen Dimethylarginin- und Stickoxid-Spiegels und der damit verbundenen unabh&auml;ngigen Variablen bei fettleibigen und schlanken Patientinnen mit polyzystischem Ovarsyndrom.<br data-start=\"8469\" data-end=\"8472\"><em data-start=\"8472\" data-end=\"8501\">Gynecological Endocrinology<\/em>, 27(9), 609-614.<br data-start=\"8518\" data-end=\"8521\">Doi: 10.3109\/09513590.2010.507291<br data-start=\"8554\" data-end=\"8557\">(Publication No: 3493369)<\/p>\n<\/li><li><p data-start=\"8589\" data-end=\"8887\"><strong data-start=\"8589\" data-end=\"8667\">Meray Onur, T&uuml;rk&ccedil;&uuml;o&#287;lu Ilg&#305;n, Meydanl&#305; Mehmet Mutlu, Kafkasl&#305; Ay&#351;e (2010).<\/strong><br data-start=\"8667\" data-end=\"8670\">Risk of malignancy index is not sensitive in detecting non-epithelial ovarian cancer and borderline ovarian tumor.<br data-start=\"8784\" data-end=\"8787\"><em data-start=\"8787\" data-end=\"8844\">Journal of the Turkish-German Gynecological Association<\/em>, 1(11), 22-26.<br data-start=\"8859\" data-end=\"8862\">(Publication No: 4325680)<\/p>\n<\/li><li><p data-start=\"8894\" data-end=\"9184\"><strong data-start=\"8894\" data-end=\"8991\">Turkish Cervical Cancer And Cervical Cytology Research Group, [Meydanl&#305; Mehmet Mutlu] (2009).<\/strong><br data-start=\"8991\" data-end=\"8994\">Prevalence of cervical cytological abnormalities in Turkey.<br data-start=\"9053\" data-end=\"9056\"><em data-start=\"9056\" data-end=\"9104\">International Journal of Gynecology Obstetrics<\/em>, 106(3), 206-209.<br data-start=\"9122\" data-end=\"9125\">Doi: 10.1016\/j.ijgo.2009.04.003<br data-start=\"9156\" data-end=\"9159\">(Publication No: 4325681)<\/p>\n<\/li><li><p data-start=\"9191\" data-end=\"9510\"><strong data-start=\"9191\" data-end=\"9284\">T&uuml;rk&ccedil;&uuml;o&#287;lu Ilg&#305;n, Meydanl&#305; Mehmet Mutlu, &Uuml;st&uuml;n Yaprak, &Uuml;st&uuml;n Yusuf, Kafkasl&#305; Ay&#351;e (2009).<\/strong><br data-start=\"9284\" data-end=\"9287\">Evaluation of histopathological features and pregnancy outcomes of pregnancy associated adnexal masses.<br data-start=\"9390\" data-end=\"9393\"><em data-start=\"9393\" data-end=\"9432\">Journal of Obstetrics and Gynaecology<\/em>, 29(2), 107-109.<br data-start=\"9449\" data-end=\"9452\">Doi: 10.1080\/01443610802678804<br data-start=\"9482\" data-end=\"9485\">(Publication No: 3498294)<\/p>\n<\/li><li><p data-start=\"9517\" data-end=\"9833\"><strong data-start=\"9517\" data-end=\"9619\">&Uuml;st&uuml;n Yusuf, &Uuml;st&uuml;n Yaprak, Ovayolu Ali, Meydanl&#305; Mehmet Mutlu, Temel &#304;smail, Kafkasl&#305; Ay&#351;e (2009).<\/strong><br data-start=\"9619\" data-end=\"9622\">The effect of resveratrol on prevention of the development of postoperative adhesions in a rat model.<br data-start=\"9723\" data-end=\"9726\"><em data-start=\"9726\" data-end=\"9755\">Gynecological Endocrinology<\/em>, 23(9), 522-526.<br data-start=\"9772\" data-end=\"9775\">Doi: 10.1080\/09513590701581648<br data-start=\"9805\" data-end=\"9808\">(Publication No: 3498929)<\/p>\n<\/li><li><p data-start=\"9840\" data-end=\"10160\"><strong data-start=\"9840\" data-end=\"9947\">&Uuml;st&uuml;n Yaprak, &Uuml;st&uuml;n Yusuf, T&uuml;rk&ccedil;&uuml;o&#287;lu Ilg&#305;n, Meydanl&#305; Mehmet Mutlu, Kafkasl&#305; Ay&#351;e, Yetkin G&uuml;lay (2009).<\/strong><br data-start=\"9947\" data-end=\"9950\">Kurzfristige Wirkung von Tibolon auf das C-reaktive Protein bei hypertensiven postmenopausalen Frauen.<br data-start=\"10039\" data-end=\"10042\"><em data-start=\"10042\" data-end=\"10081\">Archives of Gynecology and Obstetrics<\/em>, 279(3), 305-309.<br data-start=\"10099\" data-end=\"10102\">Doi: 10.1007\/s00404-008-0712-6<br data-start=\"10132\" data-end=\"10135\">(Publication No: 3498299)<\/p>\n<\/li><li><p data-start=\"10167\" data-end=\"10533\"><strong data-start=\"10167\" data-end=\"10260\">Meydanl&#305; Mehmet Mutlu, T&uuml;rk&ccedil;&uuml;o&#287;lu Ilg&#305;n, &Uuml;st&uuml;n Yaprak, &Uuml;st&uuml;n Yusuf, Kafkasl&#305; Ay&#351;e (2008).<\/strong><br data-start=\"10260\" data-end=\"10263\">Meydanl&#305; Compression Suture: Neues chirurgisches Verfahren f&uuml;r postpartale Blutungen aufgrund von Uterusatonie in Verbindung mit abnormaler Plazentaadh&auml;sion.<br data-start=\"10407\" data-end=\"10410\"><em data-start=\"10410\" data-end=\"10458\">Journal of Obstetrics and Gynaecology Research<\/em>, 34(),<br data-start=\"10465\" data-end=\"10468\">Doi: 10.1111\/j.1447-0756.2008.00797.x<br data-start=\"10505\" data-end=\"10508\">(Publication No: 3498703)<\/p>\n<\/li><li><p data-start=\"10540\" data-end=\"10808\"><strong data-start=\"10540\" data-end=\"10573\">Meydanl&#305; Mehmet Mutlu (2008).<\/strong><br data-start=\"10573\" data-end=\"10576\">Wirkung der intraoperativen Sp&uuml;lung mit Alteplase auf die Adh&auml;sionsbildung bei intraperitonealer Chemotherapie (experimentelle Studie).<br data-start=\"10715\" data-end=\"10718\"><em data-start=\"10718\" data-end=\"10763\">European Journal of Gynaecological Oncology<\/em>, 29(4), 386-389.<br data-start=\"10780\" data-end=\"10783\">(Publikationsnummer: 3498699)<\/p>\n<\/li><li><p data-start=\"10815\" data-end=\"11176\"><strong data-start=\"10815\" data-end=\"10913\">Narin Mehmet Ali, &Ccedil;al&#305;&#351;kan Eray, Kay&#305;k&ccedil;&#305;o&#287;lu Fulya, Haberal Ali, Meydanl&#305; Mehmet Mutlu (2007).<\/strong><br data-start=\"10913\" data-end=\"10916\">Blood loss and power Doppler ultrasound characteristics of uterine artery blood flow after 2 levels of bilateral internal iliac artery ligation before extensive myomectomies.<br data-start=\"11090\" data-end=\"11093\"><em data-start=\"11093\" data-end=\"11131\">The Journal of Reproductive Medicine<\/em>, 52(8), 696-702.<br data-start=\"11148\" data-end=\"11151\">(Publication No: 3498948)<\/p>\n<\/li><li><p data-start=\"11183\" data-end=\"11455\"><strong data-start=\"11183\" data-end=\"11294\">&Uuml;st&uuml;n Yaprak, &Uuml;st&uuml;n Yusuf, Bay Karabulut Aysun, Do&#287;an Keziban, Meydanl&#305; Mehmet Mutlu, Sezgin B&uuml;lent (2007).<\/strong><br data-start=\"11294\" data-end=\"11297\">Increased adenosine deaminase in hydatidiform mole.<br data-start=\"11348\" data-end=\"11351\"><em data-start=\"11351\" data-end=\"11390\">Clinical Chemical Laboratory Medicine<\/em>, 45(1),<br data-start=\"11398\" data-end=\"11401\">Doi: 10.1515\/CCLM.2007.010<br data-start=\"11427\" data-end=\"11430\">(Publication No: 3498967)<\/p>\n<\/li><li><p data-start=\"11462\" data-end=\"11720\"><strong data-start=\"11462\" data-end=\"11565\">&Uuml;st&uuml;n Yaprak, &Uuml;st&uuml;n Yusuf, &Ccedil;etin Feray, Meydanl&#305; Mehmet Mutlu, Kafkasl&#305; Ay&#351;e, Sezgin B&uuml;lent (2007).<\/strong><br data-start=\"11565\" data-end=\"11568\">Effect of postpartum counseling on postpartum contraceptive use.<br data-start=\"11632\" data-end=\"11635\"><em data-start=\"11635\" data-end=\"11674\">Archives of Gynecology and Obstetrics<\/em>, 275(6), 429-432.<br data-start=\"11692\" data-end=\"11695\">(Publication No: 3500782)<\/p>\n<\/li>\n\n<li><p data-start=\"84\" data-end=\"330\">&Uuml;ST&Uuml;N Yaprak, &Uuml;ST&Uuml;N Yusuf, BAY KARABULUT Aysun, &Ouml;ZKAPLAN Esra, MEYDANLI Mehmet Mutlu, KAFKASLI Ay&#351;e (2007). Die Amyloid-A-Spiegel im Serum sind bei Pr&auml;eklampsie erh&ouml;ht. Gynecologic and obstetric investigation, 64(2), 117-20. (Ver&ouml;ffentlichung Nr.: 3498957)<\/p>\n<\/li><li><p data-start=\"332\" data-end=\"738\">&Uuml;ST&Uuml;N Yaprak, &Uuml;ST&Uuml;N Yusuf, MEYDANLI Mehmet Mutlu, KAFKASLI Ay&#351;e (2006). Auswirkungen von intranasalem 17beta-Estradiol und Raloxifen auf das Lipidprofil und Fibrinogen bei hypercholesterin&auml;mischen postmenopausalen Frauen: eine randomisierte, placebokontrollierte klinische Studie. Gyn&auml;kologische Endokrinologie: die offizielle Zeitschrift der Internationalen Gesellschaft f&uuml;r Gyn&auml;kologische Endokrinologie, 22(12), 676-9. (Ver&ouml;ffentlichung Nr.: 3498973)<\/p>\n<\/li><li><p data-start=\"740\" data-end=\"1075\">&Uuml;ST&Uuml;N Yaprak, &Uuml;ST&Uuml;N Yusuf, MEYDANLI Mehmet Mutlu, KAFKASLI Ay&#351;e, YETK&#304;N G&uuml;lay (2006). Sind polyzystische Eierst&ouml;cke mit dem Risiko kardiovaskul&auml;rer Erkrankungen verbunden wie das polyzystische Ovarsyndrom? Gynecological Endocrinology: the official journal of the International Society of Gynecological Endocrinology, 22(6), 324-8. (Ver&ouml;ffentlichungsnummer: 3500788)<\/p>\n<\/li><li><p data-start=\"1077\" data-end=\"1304\">&Uuml;ST&Uuml;N Yusuf, &Uuml;ST&Uuml;N Yaprak, KAYA Emin, MEYDANLI Mehmet Mutlu, KULAK Nal&acirc;n (2006). Erh&ouml;hte Anzahl kernhaltiger roter Blutk&ouml;rperchen: eine bev&ouml;lkerungsbasierte Studie. Das Journal der Reproduktionsmedizin, 51(1), 36-40. (Ver&ouml;ffentlichungsnummer: 3500793)<\/p>\n<\/li><li><p data-start=\"1306\" data-end=\"1634\">&Ccedil;EL&#304;K &Ouml;nder, HAS&Ccedil;ALIK &#350;eyma, SARA&Ccedil; Kaya, MEYDANLI Mehmet Mutlu, ALKAN Alpay, MIZRAK B&uuml;lent (2005). Magnetresonanzspektroskopie pr&auml;maligner und maligner Endometriumerkrankungen: eine Machbarkeitsstudie in vivo. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 118(2), 241-5. (Ver&ouml;ffentlichungsnummer: 3500816)<\/p>\n<\/li><li><p data-start=\"1636\" data-end=\"1899\">HASCALIK &#350;eyma, &Ccedil;EL&#304;K &Ouml;nder, SARA&Ccedil; Kaya, MEYDANLI Mehmet Mutlu, ALKAN Alpay, MIZRAK B&uuml;lent (2005). Metabolische Ver&auml;nderungen bei pelvinen L&auml;sionen: Ergebnisse der protonen-mR-spektroskopischen Bildgebung. Gynecologic and Obstetric Investigation, 60(3), 121-7. (Ver&ouml;ffentlichungsnummer: 3500804)<\/p>\n<\/li><li><p data-start=\"1901\" data-end=\"2259\">MEYDANLI Mehmet Mutlu, &Ccedil;ALI&#350;KAN Eray, BURAK Feza, NAR&#304;N Mehmet Ali, ATMACA Ru&#351;en (2003). Weheneinleitung nach der Geburt mit 25 Mikrogramm vs. 50 Mikrogramm intravaginalem Misoprostol. International Journal of Gynaecology and Obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 81(3), 249-55. (Ver&ouml;ffentlichungsnummer: 3500833)<\/p>\n<\/li><li><p data-start=\"2261\" data-end=\"2518\">MEYDANLI Mehmet Mutlu, &Ccedil;ALI&#350;KAN Eray, HABERAL Ali (2003). Vorhersage von unerw&uuml;nschten Ergebnissen im Zusammenhang mit vaginalem Misoprostol zur Geburtseinleitung. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 110(2), 143-8. (Ver&ouml;ffentlichungsnummer: 3500838)<\/p>\n<\/li><li><p data-start=\"2520\" data-end=\"2787\">MEYDANLI Mehmet Mutlu, ERGUVAN Rezzan, ALTINOK Mustafa Tayfun, ATAO&#286;LU &Ouml;m&uuml;r, KAFKASLI Ay&#351;e (2003). Seltener Fall eines neuroendokrinen kleinzelligen Karzinoms des Endometriums mit paraneoplastischer membran&ouml;ser Glomerulonephritis. Tumori, 89(2), 213-7. (Ver&ouml;ffentlichung Nr.: 3501043)<\/p>\n<\/li><li><p data-start=\"2789\" data-end=\"3046\">&Ccedil;ALI&#350;KAN Eray, D&#304;LBAZ Berna, MEYDANLI Mehmet Mutlu, &Ouml;ZT&Uuml;RK Nilg&uuml;n, NAR&#304;N Mehmet Ali, HABERAL Ali (2003). Orales Misoprostol f&uuml;r die dritte Phase der Wehen: eine randomisierte kontrollierte Studie. Geburtshilfe und Gyn&auml;kologie, 101(5 Pt 1), 921-8. (Ver&ouml;ffentlichungsnummer: 3501058)<\/p>\n<\/li><li><p data-start=\"3048\" data-end=\"3302\">MEYDANLI Mehmet Mutlu, KARADA&#286; Ne&#351;e, ATAO&#286;LU &Ouml;m&uuml;r, KAFKASLI Ay&#351;e (2002). Uterusmetastasen aus einem infiltrierenden duktalen Karzinom der Brust bei einer Patientin, die Tamoxifen erhielt. The Breast, 11(4), 353-356. Doi: 10.1054\/brst.2002.0447 (Ver&ouml;ffentlichungsnummer: 3493101)<\/p>\n<\/li><li><p data-start=\"3304\" data-end=\"3608\">&Ccedil;ALI&#350;KAN Eray, MEYDANLI Mehmet Mutlu, D&#304;LBAZ Berna, AYKAN Burcu, S&Ouml;NMEZER Meral, HABERAL Ali (2002). Ist rektales Misoprostol bei der Behandlung der dritten Phase der Wehen wirklich wirksam? Eine randomisierte kontrollierte Studie. American Journal of Obstetrics and Gynecology, 187(4), 1038-45. (Ver&ouml;ffentlichungsnummer: 3501086)<\/p>\n<\/li><li><p data-start=\"3610\" data-end=\"3887\">KAYIK&Ccedil;IO&#286;LU Fulya, BORAN Nurettin, MEYDANLI Mehmet Mutlu, K&Ouml;SE Mehmet Faruk, B&Uuml;LB&Uuml;L Dilek (2002). Ist die Schnellschnittdiagnose ein zuverl&auml;ssiger Leitfaden f&uuml;r die chirurgische Behandlung des Endometriumkarzinoms im Stadium I? Acta Oncologica (Stockholm, Schweden), 41(5), 444-6. (Ver&ouml;ffentlichungsnummer: 3501399)<\/p>\n<\/li><li><p data-start=\"3889\" data-end=\"4237\">MEYDANLI Mehmet Mutlu, D&#304;LBAZ Berna, &Ccedil;ALI&#350;KAN Eray, D&#304;LBAZ Serdar, HABERAL Ali (2001). Risikofaktoren f&uuml;r das Mekoniumaspirationssyndrom bei S&auml;uglingen, die mit dickem Mekonium geboren werden. International Journal of Gynaecology and Obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 72(1), 9-15. (Ver&ouml;ffentlichungsnummer: 3467849)<\/p>\n<\/li><li><p data-start=\"4239\" data-end=\"4467\">K&Ouml;SE Mehmet Faruk, MEYDANLI Mehmet Mutlu, TULUNAY Hakk&#305; G&ouml;khan (2006). Gemcitabin plus Carboplatin bei platinsensitivem rezidivierendem Ovarialkarzinom. Expert Review of Anticancer Therapy, 6(3), 437-443. (Ver&ouml;ffentlichung Nr.: 4325683)<\/p>\n<\/li><li><p data-start=\"4469\" data-end=\"4845\">TOPFEDA&#304;S&#304; &Ouml;ZKAN NAZLI, SARI ERKAN, G&Ouml;RKEM &Uuml;M&#304;T, BAYRAMO&#286;LU HAT&#304;CE, AKBAY SERAP, MEYDANLI Mehmet Mutlu, G&Uuml;NG&Ouml;R TAYFUN (2017). Iatrogene Implantation von Plazentagewebe nach einer Dilatation und K&uuml;rettage im ersten Trimester, die sich als uterine Masse darstellt: Ein Bericht &uuml;ber zwei F&auml;lle. Journal of Obstetrics and Gynaecology, 1-3. Doi: 10.1080\/01443615.2017.1286301 (Ver&ouml;ffentlichungsnummer: 3493122)<\/p>\n<\/li><li><p data-start=\"4847\" data-end=\"5143\">SEL&Ccedil;UK &#304;lker, &Ouml;ZDAL B&uuml;lent, T&Uuml;RKER Meng&uuml;, USUBUTUN Alp, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu (2015). Mukoepidermoides Karzinom der Zervix uteri: Eine eigenst&auml;ndige pathologische und klinische Entit&auml;t. Case Reports in Obstetrics and Gynecology, 2015, 1-4. Doi: 10.1155\/2015\/491875 (Ver&ouml;ffentlichungsnummer: 3493319)<\/p>\n<\/li><li><p data-start=\"5145\" data-end=\"5471\">&Ouml;ZDAL B&uuml;lent, &Ouml;Z Murat, KORKMAZ Elmas, ATAO&#286;LU &Ouml;m&uuml;r, G&Uuml;NG&Ouml;R Tayfun, MEYDANLI Mehmet Mutlu (2014). B&ouml;sartiger peripherer Nervenscheidentumor der Vulva, eine ungew&ouml;hnliche Differentialdiagnose f&uuml;r eine vulv&auml;re Masse. International Journal of Surgery Case Reports, 5(11), 793-795. , Doi: 10.1016\/j.ijscr.2014.09.006 (Ver&ouml;ffentlichungsnummer: 3493329)<\/p>\n<\/li><li><p data-start=\"5473\" data-end=\"5618\">D&#304;R&#304;CAN Abuzer, MEYDANLI Mehmet Mutlu (2009). Torsion der wandernden Milz. Bratislavske Lekarske Listy, 110(11), 723-5. (Ver&ouml;ffentlichungsnummer: 3498290)<\/p>\n<\/li><li><p data-start=\"5620\" data-end=\"5881\">&Uuml;ST&Uuml;N Yaprak, &Uuml;ST&Uuml;N Yusuf, DO&#286;AN Keziban, MEYDANLI Mehmet Mutlu (2007). Ovarialkarzinom als Zufallsbefund bei einem Kaiserschnitt bei einer pr&auml;eklamptischen Frau: Fallbericht. Europ&auml;ische Zeitschrift f&uuml;r gyn&auml;kologische Onkologie, 28(5), 423-4. (Ver&ouml;ffentlichung Nr.: 3498939)<\/p>\n<\/li><li><p data-start=\"5883\" data-end=\"6102\">MEYDANLI Mehmet Mutlu, &Uuml;ST&Uuml;N Yusuf, YAL&Ccedil;IN &Ouml;mer Tar&#305;k (2006). Beckenorganprolaps als Komplikation einer Schwangerschaft im dritten Trimester. Ein Fallbericht. Gynecologic and Obstetric Investigation, 61(3), 133-4. (Ver&ouml;ffentlichungsnummer: 3500796)<\/p>\n<\/li><li><p data-start=\"6104\" data-end=\"6369\">ERGUVAN Rezzan, MEYDANLI Mehmet Mutlu, ALKAN Alpay, EDALI Mehmet Naci, G&Ouml;K&Ccedil;E Hasan, KAFKASLI Ay&#351;e (2003). Abszess bei Adenomyose, der eine b&ouml;sartige Erkrankung bei einer 54-j&auml;hrigen Frau vort&auml;uscht. Infektionskrankheiten in der Geburtshilfe und Gyn&auml;kologie, 11(1), 59-64. (Ver&ouml;ffentlichungsnummer: 3500823)<\/p>\n<\/li><li><p data-start=\"6371\" data-end=\"6589\">MEYDANLI Mehmet Mutlu, K&Uuml;&Ccedil;&Uuml;KAL&#304; T&uuml;rkan, USUBUTUN Alp, ATAO&#286;LU &Ouml;m&uuml;r, KAFKASLI Ay&#351;e (2002). Epithelioider trophoblastischer Tumor der Endozervix: ein Fallbericht. Gynecologic Oncology, 87(2), 219-24. (Ver&ouml;ffentlichung Nr.: 3501415)<\/p>\n\n<\/li><\/ul><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t","protected":false},"excerpt":{"rendered":"<p>Prof. Dr. med. Mehmet Mutlu Meydanl\u0131<\/p>\n","protected":false},"author":3,"featured_media":73152,"parent":14366,"menu_order":38,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[292],"tags":[187],"class_list":["post-16605","page","type-page","status-publish","has-post-thumbnail","hentry","category-gynakologische-onkologie","tag-medicalpoint-gaziantep-krankenhaus","bf-cat-292","bf-cat-544"],"rankMath":{"parentDomain":"medicalpointinternational.com","noFollowDomains":[],"noFollowExcludeDomains":[],"noFollowExternalLinks":false,"featuredImageNotice":"Das angezeigte Beitragsbild sollte mindestens 200x200 px gro\u00df sein, damit Facebook und andere Social-Media-Websites es \u00fcbernehmen.","pluginReviewed":false,"postSettings":{"linkSuggestions":true,"useFocusKeyword":false},"frontEndScore":false,"postName":"prof-mehmet-mutlu-meydanli","permalinkFormat":"https:\/\/medicalpointinternational.com\/de\/%pagename%\/","showLockModifiedDate":true,"assessor":{"focusKeywordLink":"https:\/\/medicalpointinternational.com\/wp-admin\/edit.php?focus_keyword=%focus_keyword%&post_type=%post_type%","hasTOCPlugin":true,"primaryTaxonomy":false,"serpData":{"title":"","description":"","focusKeywords":"","pillarContent":false,"canonicalUrl":"","breadcrumbTitle":"","advancedRobots":{"max-snippet":"-1","max-video-preview":"-1","max-image-preview":"large"},"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":"","facebookHasOverlay":false,"facebookImageOverlay":"","facebookAuthor":"","twitterCardType":"","twitterUseFacebook":true,"twitterTitle":"","twitterDescription":"","twitterImage":"","twitterImageID":"","twitterHasOverlay":false,"twitterImageOverlay":"","twitterPlayerUrl":"","twitterPlayerSize":"","twitterPlayerStream":"","twitterPlayerStreamCtype":"","twitterAppDescription":"","twitterAppIphoneName":"","twitterAppIphoneID":"","twitterAppIphoneUrl":"","twitterAppIpadName":"","twitterAppIpadID":"","twitterAppIpadUrl":"","twitterAppGoogleplayName":"","twitterAppGoogleplayID":"","twitterAppGoogleplayUrl":"","twitterAppCountry":"","robots":{"index":true},"twitterAuthor":"Benutzername","primaryTerm":0,"authorName":"Ali \u00d6zgen\u00e7","titleTemplate":"%title% %sep% %sitename%","descriptionTemplate":"%excerpt%","showScoreFrontend":true,"lockModifiedDate":false},"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":{"A":"[\\u0041\\u24B6\\uFF21\\u00C0\\u00C1\\u00C2\\u1EA6\\u1EA4\\u1EAA\\u1EA8\\u00C3\\u0100\\u0102\\u1EB0\\u1EAE\\u1EB4\\u1EB2\\u0226\\u01E0\\u01DE\\u1EA2\\u00C5\\u01FA\\u01CD\\u0200\\u0202\\u1EA0\\u1EAC\\u1EB6\\u1E00\\u0104\\u023A\\u2C6F]","AA":"[\\uA732]","AE":"[\\u00C6\\u01FC\\u01E2\\u00C4]","AO":"[\\uA734]","AU":"[\\uA736]","AV":"[\\uA738\\uA73A]","AY":"[\\uA73C]","B":"[\\u0042\\u24B7\\uFF22\\u1E02\\u1E04\\u1E06\\u0243\\u0182\\u0181]","C":"[\\u0043\\u24B8\\uFF23\\u0106\\u0108\\u010A\\u010C\\u00C7\\u1E08\\u0187\\u023B\\uA73E]","D":"[\\u0044\\u24B9\\uFF24\\u1E0A\\u010E\\u1E0C\\u1E10\\u1E12\\u1E0E\\u0110\\u018B\\u018A\\u0189\\uA779]","DZ":"[\\u01F1\\u01C4]","Dz":"[\\u01F2\\u01C5]","E":"[\\u0045\\u24BA\\uFF25\\u00C8\\u00C9\\u00CA\\u1EC0\\u1EBE\\u1EC4\\u1EC2\\u1EBC\\u0112\\u1E14\\u1E16\\u0114\\u0116\\u00CB\\u1EBA\\u011A\\u0204\\u0206\\u1EB8\\u1EC6\\u0228\\u1E1C\\u0118\\u1E18\\u1E1A\\u0190\\u018E]","F":"[\\u0046\\u24BB\\uFF26\\u1E1E\\u0191\\uA77B]","G":"[\\u0047\\u24BC\\uFF27\\u01F4\\u011C\\u1E20\\u011E\\u0120\\u01E6\\u0122\\u01E4\\u0193\\uA7A0\\uA77D\\uA77E]","H":"[\\u0048\\u24BD\\uFF28\\u0124\\u1E22\\u1E26\\u021E\\u1E24\\u1E28\\u1E2A\\u0126\\u2C67\\u2C75\\uA78D]","I":"[\\u0049\\u24BE\\uFF29\\u00CC\\u00CD\\u00CE\\u0128\\u012A\\u012C\\u0130\\u00CF\\u1E2E\\u1EC8\\u01CF\\u0208\\u020A\\u1ECA\\u012E\\u1E2C\\u0197]","J":"[\\u004A\\u24BF\\uFF2A\\u0134\\u0248]","K":"[\\u004B\\u24C0\\uFF2B\\u1E30\\u01E8\\u1E32\\u0136\\u1E34\\u0198\\u2C69\\uA740\\uA742\\uA744\\uA7A2]","L":"[\\u004C\\u24C1\\uFF2C\\u013F\\u0139\\u013D\\u1E36\\u1E38\\u013B\\u1E3C\\u1E3A\\u0141\\u023D\\u2C62\\u2C60\\uA748\\uA746\\uA780]","LJ":"[\\u01C7]","Lj":"[\\u01C8]","M":"[\\u004D\\u24C2\\uFF2D\\u1E3E\\u1E40\\u1E42\\u2C6E\\u019C]","N":"[\\u004E\\u24C3\\uFF2E\\u01F8\\u0143\\u00D1\\u1E44\\u0147\\u1E46\\u0145\\u1E4A\\u1E48\\u0220\\u019D\\uA790\\uA7A4]","NJ":"[\\u01CA]","Nj":"[\\u01CB]","O":"[\\u004F\\u24C4\\uFF2F\\u00D2\\u00D3\\u00D4\\u1ED2\\u1ED0\\u1ED6\\u1ED4\\u00D5\\u1E4C\\u022C\\u1E4E\\u014C\\u1E50\\u1E52\\u014E\\u022E\\u0230\\u022A\\u1ECE\\u0150\\u01D1\\u020C\\u020E\\u01A0\\u1EDC\\u1EDA\\u1EE0\\u1EDE\\u1EE2\\u1ECC\\u1ED8\\u01EA\\u01EC\\u00D8\\u01FE\\u0186\\u019F\\uA74A\\uA74C]","OE":"[\\u00D6]","OI":"[\\u01A2]","OO":"[\\uA74E]","OU":"[\\u0222]","P":"[\\u0050\\u24C5\\uFF30\\u1E54\\u1E56\\u01A4\\u2C63\\uA750\\uA752\\uA754]","Q":"[\\u0051\\u24C6\\uFF31\\uA756\\uA758\\u024A]","R":"[\\u0052\\u24C7\\uFF32\\u0154\\u1E58\\u0158\\u0210\\u0212\\u1E5A\\u1E5C\\u0156\\u1E5E\\u024C\\u2C64\\uA75A\\uA7A6\\uA782]","S":"[\\u0053\\u24C8\\uFF33\\u1E9E\\u015A\\u1E64\\u015C\\u1E60\\u0160\\u1E66\\u1E62\\u1E68\\u0218\\u015E\\u2C7E\\uA7A8\\uA784]","T":"[\\u0054\\u24C9\\uFF34\\u1E6A\\u0164\\u1E6C\\u021A\\u0162\\u1E70\\u1E6E\\u0166\\u01AC\\u01AE\\u023E\\uA786]","TZ":"[\\uA728]","U":"[\\u0055\\u24CA\\uFF35\\u00D9\\u00DA\\u00DB\\u0168\\u1E78\\u016A\\u1E7A\\u016C\\u01DB\\u01D7\\u01D5\\u01D9\\u1EE6\\u016E\\u0170\\u01D3\\u0214\\u0216\\u01AF\\u1EEA\\u1EE8\\u1EEE\\u1EEC\\u1EF0\\u1EE4\\u1E72\\u0172\\u1E76\\u1E74\\u0244]","UE":"[\\u00DC]","V":"[\\u0056\\u24CB\\uFF36\\u1E7C\\u1E7E\\u01B2\\uA75E\\u0245]","VY":"[\\uA760]","W":"[\\u0057\\u24CC\\uFF37\\u1E80\\u1E82\\u0174\\u1E86\\u1E84\\u1E88\\u2C72]","X":"[\\u0058\\u24CD\\uFF38\\u1E8A\\u1E8C]","Y":"[\\u0059\\u24CE\\uFF39\\u1EF2\\u00DD\\u0176\\u1EF8\\u0232\\u1E8E\\u0178\\u1EF6\\u1EF4\\u01B3\\u024E\\u1EFE]","Z":"[\\u005A\\u24CF\\uFF3A\\u0179\\u1E90\\u017B\\u017D\\u1E92\\u1E94\\u01B5\\u0224\\u2C7F\\u2C6B\\uA762]","a":"[\\u0061\\u24D0\\uFF41\\u1E9A\\u00E0\\u00E1\\u00E2\\u1EA7\\u1EA5\\u1EAB\\u1EA9\\u00E3\\u0101\\u0103\\u1EB1\\u1EAF\\u1EB5\\u1EB3\\u0227\\u01E1\\u01DF\\u1EA3\\u00E5\\u01FB\\u01CE\\u0201\\u0203\\u1EA1\\u1EAD\\u1EB7\\u1E01\\u0105\\u2C65\\u0250]","aa":"[\\uA733]","ae":"[\\u00E6\\u01FD\\u01E3\\u00E4]","ao":"[\\uA735]","au":"[\\uA737]","av":"[\\uA739\\uA73B]","ay":"[\\uA73D]","b":"[\\u0062\\u24D1\\uFF42\\u1E03\\u1E05\\u1E07\\u0180\\u0183\\u0253]","c":"[\\u0063\\u24D2\\uFF43\\u0107\\u0109\\u010B\\u010D\\u00E7\\u1E09\\u0188\\u023C\\uA73F\\u2184]","d":"[\\u0064\\u24D3\\uFF44\\u1E0B\\u010F\\u1E0D\\u1E11\\u1E13\\u1E0F\\u0111\\u018C\\u0256\\u0257\\uA77A]","dz":"[\\u01F3\\u01C6]","e":"[\\u0065\\u24D4\\uFF45\\u00E8\\u00E9\\u00EA\\u1EC1\\u1EBF\\u1EC5\\u1EC3\\u1EBD\\u0113\\u1E15\\u1E17\\u0115\\u0117\\u00EB\\u1EBB\\u011B\\u0205\\u0207\\u1EB9\\u1EC7\\u0229\\u1E1D\\u0119\\u1E19\\u1E1B\\u0247\\u025B\\u01DD]","f":"[\\u0066\\u24D5\\uFF46\\u1E1F\\u0192\\uA77C]","g":"[\\u0067\\u24D6\\uFF47\\u01F5\\u011D\\u1E21\\u011F\\u0121\\u01E7\\u0123\\u01E5\\u0260\\uA7A1\\u1D79\\uA77F]","h":"[\\u0068\\u24D7\\uFF48\\u0125\\u1E23\\u1E27\\u021F\\u1E25\\u1E29\\u1E2B\\u1E96\\u0127\\u2C68\\u2C76\\u0265]","hv":"[\\u0195]","i":"[\\u0069\\u24D8\\uFF49\\u00EC\\u00ED\\u00EE\\u0129\\u012B\\u012D\\u00EF\\u1E2F\\u1EC9\\u01D0\\u0209\\u020B\\u1ECB\\u012F\\u1E2D\\u0268\\u0131]","j":"[\\u006A\\u24D9\\uFF4A\\u0135\\u01F0\\u0249]","k":"[\\u006B\\u24DA\\uFF4B\\u1E31\\u01E9\\u1E33\\u0137\\u1E35\\u0199\\u2C6A\\uA741\\uA743\\uA745\\uA7A3]","l":"[\\u006C\\u24DB\\uFF4C\\u0140\\u013A\\u013E\\u1E37\\u1E39\\u013C\\u1E3D\\u1E3B\\u017F\\u0142\\u019A\\u026B\\u2C61\\uA749\\uA781\\uA747]","lj":"[\\u01C9]","m":"[\\u006D\\u24DC\\uFF4D\\u1E3F\\u1E41\\u1E43\\u0271\\u026F]","n":"[\\u006E\\u24DD\\uFF4E\\u01F9\\u0144\\u00F1\\u1E45\\u0148\\u1E47\\u0146\\u1E4B\\u1E49\\u019E\\u0272\\u0149\\uA791\\uA7A5]","nj":"[\\u01CC]","o":"[\\u006F\\u24DE\\uFF4F\\u00F2\\u00F3\\u00F4\\u1ED3\\u1ED1\\u1ED7\\u1ED5\\u00F5\\u1E4D\\u022D\\u1E4F\\u014D\\u1E51\\u1E53\\u014F\\u022F\\u0231\\u022B\\u1ECF\\u0151\\u01D2\\u020D\\u020F\\u01A1\\u1EDD\\u1EDB\\u1EE1\\u1EDF\\u1EE3\\u1ECD\\u1ED9\\u01EB\\u01ED\\u00F8\\u01FF\\u0254\\uA74B\\uA74D\\u0275]","oe":"[\\u00f6]","oi":"[\\u01A3]","ou":"[\\u0223]","oo":"[\\uA74F]","p":"[\\u0070\\u24DF\\uFF50\\u1E55\\u1E57\\u01A5\\u1D7D\\uA751\\uA753\\uA755]","q":"[\\u0071\\u24E0\\uFF51\\u024B\\uA757\\uA759]","r":"[\\u0072\\u24E1\\uFF52\\u0155\\u1E59\\u0159\\u0211\\u0213\\u1E5B\\u1E5D\\u0157\\u1E5F\\u024D\\u027D\\uA75B\\uA7A7\\uA783]","s":"[\\u0073\\u24E2\\uFF53\\u015B\\u1E65\\u015D\\u1E61\\u0161\\u1E67\\u1E63\\u1E69\\u0219\\u015F\\u023F\\uA7A9\\uA785\\u1E9B]","ss":"[\\u00DF]","t":"[\\u0074\\u24E3\\uFF54\\u1E6B\\u1E97\\u0165\\u1E6D\\u021B\\u0163\\u1E71\\u1E6F\\u0167\\u01AD\\u0288\\u2C66\\uA787]","tz":"[\\uA729]","u":"[\\u0075\\u24E4\\uFF55\\u00F9\\u00FA\\u00FB\\u0169\\u1E79\\u016B\\u1E7B\\u016D\\u01DC\\u01D8\\u01D6\\u01DA\\u1EE7\\u016F\\u0171\\u01D4\\u0215\\u0217\\u01B0\\u1EEB\\u1EE9\\u1EEF\\u1EED\\u1EF1\\u1EE5\\u1E73\\u0173\\u1E77\\u1E75\\u0289]","ue":"[\\u00FC]","v":"[\\u0076\\u24E5\\uFF56\\u1E7D\\u1E7F\\u028B\\uA75F\\u028C]","vy":"[\\uA761]","w":"[\\u0077\\u24E6\\uFF57\\u1E81\\u1E83\\u0175\\u1E87\\u1E85\\u1E98\\u1E89\\u2C73]","x":"[\\u0078\\u24E7\\uFF58\\u1E8B\\u1E8D]","y":"[\\u0079\\u24E8\\uFF59\\u1EF3\\u00FD\\u0177\\u1EF9\\u0233\\u1E8F\\u00FF\\u1EF7\\u1E99\\u1EF5\\u01B4\\u024F\\u1EFF]","z":"[\\u007A\\u24E9\\uFF5A\\u017A\\u1E91\\u017C\\u017E\\u1E93\\u1E95\\u01B6\\u0225\\u0240\\u2C6C\\uA763]"},"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasRedirection":true,"hasBreadcrumb":true},"homeUrl":"https:\/\/medicalpointinternational.com\/de\/","objectID":16605,"objectType":"post","locale":"de","localeFull":"de_DE","overlayImages":{"play":{"name":"Wiedergabezeichen","url":"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","path":"\/home\/medicalpointint\/public_html\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","position":"middle_center"},"gif":{"name":"GIF-Symbol","url":"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","path":"\/home\/medicalpointint\/public_html\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","position":"middle_center"}},"defautOgImage":"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2024\/12\/Medical-Point-International-Hospital-Empty-Pic.png","customPermalinks":true,"isUserRegistered":true,"autoSuggestKeywords":true,"connectSiteUrl":"https:\/\/rankmath.com\/auth?site=https%3A%2F%2Fmedicalpointinternational.com%2Fde%2F&r=https%3A%2F%2Fmedicalpointinternational.com%2Fde%2Fwp-json%2Fwp%2Fv2%2Fpages%2F16605%3Fnonce%3D0a6630d761&pro=1","maxTags":100,"trendsIcon":"<svg viewBox=\"0 0 610 610\"><path d=\"M18.85,446,174.32,290.48l58.08,58.08L76.93,504a14.54,14.54,0,0,1-20.55,0L18.83,466.48a14.54,14.54,0,0,1,0-20.55Z\" style=\"fill:#4285f4\"\/><path d=\"M242.65,242.66,377.59,377.6l-47.75,47.75a14.54,14.54,0,0,1-20.55,0L174.37,290.43l47.75-47.75A14.52,14.52,0,0,1,242.65,242.66Z\" style=\"fill:#ea4335\"\/><polygon points=\"319.53 319.53 479.26 159.8 537.34 217.88 377.61 377.62 319.53 319.53\" style=\"fill:#fabb05\"\/><path d=\"M594.26,262.73V118.61h0a16.94,16.94,0,0,0-16.94-16.94H433.2a16.94,16.94,0,0,0-12,28.92L565.34,274.71h0a16.94,16.94,0,0,0,28.92-12Z\" style=\"fill:#34a853\"\/><rect width=\"610\" height=\"610\" style=\"fill:none\"\/><\/svg>","showScore":true,"siteFavIcon":"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2024\/12\/Medical-Point-International-Hospital-Empty-Pic-150x150.png","canUser":{"general":false,"advanced":false,"snippet":false,"social":false,"analysis":false,"analytics":false,"content_ai":false},"showKeywordIntent":true,"isPro":true,"is_front_page":false,"trendsUpgradeLink":"https:\/\/rankmath.com\/pricing\/?utm_source=Plugin&utm_medium=CE%20General%20Tab%20Trends&utm_campaign=WP","trendsUpgradeLabel":"Upgraden","trendsPreviewImage":"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/trends-preview.jpg","currentEditor":false,"homepageData":{"assessor":{"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":true,"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasBreadcrumb":true,"serpData":{"title":"%sitename% %page% %sep% %sitedesc%","description":"","titleTemplate":"%sitename% %page% %sep% %sitedesc%","descriptionTemplate":"","focusKeywords":"","breadcrumbTitle":"Startseite","robots":{"index":true},"advancedRobots":{"max-snippet":"-1","max-video-preview":"-1","max-image-preview":"large"},"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":""}}},"isAnalyticsConnected":false,"tocTitle":"Table of Contents","tocExcludeHeadings":[],"listStyle":"ul"},"_links":{"self":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/16605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/comments?post=16605"}],"version-history":[{"count":15,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/16605\/revisions"}],"predecessor-version":[{"id":75444,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/16605\/revisions\/75444"}],"up":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/14366"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/media\/73152"}],"wp:attachment":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/media?parent=16605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/categories?post=16605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/tags?post=16605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}